jagomart
digital resources
picture1_Excel Sample Sheet 33646 | Interactive Costing Tool Tariff Data 2022 2023


 212x       Filetype XLSX       File size 0.34 MB       Source: www.nihr.ac.uk


File: Excel Sample Sheet 33646 | Interactive Costing Tool Tariff Data 2022 2023
sheet 1 procedures 20222023 version 13 workbook content this definition and tariff has been created to assist both industry and nhs partners to create consistent and meaningful costings for industry ...

icon picture XLSX Filetype Excel XLSX | Posted on 10 Aug 2022 | 3 years ago
Partial file snippet.
Sheet 1: Procedures
2022-2023: Version 1.3












Workbook content:





This definition and tariff has been created to assist both Industry and NHS partners to create consistent and meaningful costings for Industry sponsored research within the NHS.












Values within this tariff solely define the relevant labour time required by research staff to initiate, carry out or report on the activity described within the Investigation and Intervention Tariff document.












Please note that all values included below are guidelines and may require adaptaion due to complexity or additional staff involvement.





All entries contain the following:












●       Grantplan or NIHR Coding - Codes from the Industry Grantplan software or NIHR coding (for reference) where Grantplan coding is absent.












●       Activity Description - Brief Description of activity taking place












●       Department - Defined department that covers the activity (this may vary from one NHS organisation to another.












●       Notes - Whether the activity is a single investigation, an intervention with associated investigation or a unit cost activity at setup or during the project.












●       Timings - The defined unitary timings for the activity



















Please note that these are NHS baseline timimgs only and do not represent costs provided by commercial or academic units. A degree of consideration will be required in order to cost any of these items in conjunction with external NHS SLAs contract to either of these entities.












The following values have been used to convert the timings in this document into unit costs within the tool:












Role Cost per Hour




Medical £97




Manager/ Nurse £40




Admin/ Data £24


















Grantplan or NIHR Coding Activity Description Department Notes Clinical Time
[Consultant]
Nurse Time
[Band 7]
Admin Time
[Band 4]
NIHR_PRC_001 Informed consent STUDY TEAM Nurse time refers to the study being discussed with the patient prior to consent and signature which is represented by the Clinical (Doctor) time. Nurse time will include the patients being informed of their rights (informed consent process according to GCP guidelines), preliminary reviews of inclusion/exclusion criteria, concomitant medications and medical (with condition history if applicable) and previous laboratory test results if appropriate (please note that these reviews may/will also be conducted by the doctor at the screening visits). Times allocated are dependent on complexity of study and the patient group (cognitive level) and the following time are provided as initial guidance only: From 30 mins for simple complexity (Observational, Genetic databases), From 45 mins medium complexity (majority of types of studies), From 60 mins complex (e.g. monoclonal studies), From 15 mins ADDITIONAL time if patient population requires (e.g. level of cognitive function). Other considerations which may require additional time includes: Pre-screen checks, pre-screen discussion with patient (nurse and PI or referring consultant), handling patient call query when reviewing information, attendance at Screening visit with further questions, the Caregiver or family members may have queries, which may be more common for patient home visits or inclusion of genetic sample requirements. Re-consenting patients following protocol amendment may be required and could be included as an Additional Itemised Cost line item to enable invoicing as required. 60 60 0
NIHR_PRC_002 Consent for Genetic Sample STUDY TEAM Nurse time refers to the implications of genetic sampling being discussed with the patient prior to consent for this procedure as a standalone consent. 10 10 0
NIHR_PRC_003 Medical history STUDY TEAM May include other information covering demographics, concomitant illnesses or inclusion/exclusion related questions.
For some conditions, further information maybe needed around previous treatments or condition history e.g. Diabetes, oncology, Alzheimer''s Disease which may require more time to be included. This could add from 15 mins Clinical time and from 60 mins nurse time depending on requirements and whether discussion have been part of informed consent process
30 30 0
NIHR_PRC_004 Blood sample - collection only STUDY TEAM Blood sample collection only. Chargeable per patient collection (blood draw) not per tube. Covers preparation (e.g. cannulation if used), equipment, collection and paperwork. Cost EXCLUDES processing - if required please select additional line item for blood sample collection processing. May need to consider time adjustments when collection is outside of normal working hours (e.g. access restrictions). Where applicable ensure investigator time is included for sign-off’. May be required for pregnancy test (serum hCG) - amend descriptive text to show inclusion as required. 0 15 0
NIHR_PRC_005 Blood sample - collection processing STUDY TEAM Blood sample collection processing only (EXCLUDES collection - this is a separate line item). Times to be adjusted as per processing requirements in the protocol. The separate Specimen dispatch item should be selected if using off-site lab (e.g. central lab). May need to consider time adjustments when collection is outside of normal working hours (e.g. access restrictions). Where applicable ensure investigator time is included for sign-off. May be required for pregnancy test (serum hCG at local or central lab) - amend descriptive text to show inclusion as required. 0 30 0
NIHR_PRC_006 Specimen Dispatch by post/courier STUDY TEAM Time for staff to package specimens to confirm to appropriate UN Packing standard, arrangement of courier and associated paperwork. Separate line items enables reflective of batch couriering for patient samples if possible. 0 30 0
NIHR_PRC_007 Vital Signs measurements (Temp, BP, Pulse and respiration) STUDY TEAM Covering Temperature, blood pressure, pulse rate and respiration rate 10 10 0
NIHR_PRC_008 Weight & Height (including BMI if required) STUDY TEAM Additional time may be required if patient has mobility or disability which requires transfer from wheelchair and back or support requirements during measurement. Time may vary depending on equipment or BMI calculation method required by protocol. 0 5 0
NIHR_PRC_009 Waist and Hip Circumference STUDY TEAM Waist and Hip Circumference measurement 0 0 5
NIHR_PRC_010 Blood pressure (only) STUDY TEAM Line item for use when measurement is performed independently of the vital signs assessments. Time is dependent on specific instructions 0 10 0
NIHR_PRC_011 Physical examination STUDY TEAM Timings assume patient without a condition that would result in requiring additional time e.g.. mobility problems
Nurse may need follow up by contacting GP or other consultants for results of previous tests.
May require different examinations e.g. eye examinations by fundoscopy (5min clinical time) for diabetic patients which would be helpful to list in procedure description to aid review
30 20 0
NIHR_PRC_012 Urinalysis - Urine collection only (at clinic) STUDY TEAM Time allocated covers sample collection only. Processing of sample is included as a separate line item. Time value may need adjustment to include time for support for patient to get on/off the toilet if required. May be required for pregnancy test. 0 5 0
NIHR_PRC_013 Urinalysis - Urine processing (dipstick or sample preparation) STUDY TEAM Processing of collected Urine (e.g. volume measurement, acidification, centrifugation, transfer of containers) for lab investigations. Processing time may be adjusted to reflect the processing requirements of the protocol including sending off a culture and sensitivity to local labs and following up results. Associated investigation cost may also be required. May be required for pregnancy test. 0 5 0
NIHR_PRC_014 Spirometry STUDY TEAM Includes preparation, use and cleaning of spirometer equipment and standard consumables for investigation 0 20 0
NIHR_PRC_015 Randomisation (manual, IVRS or IWRS) STUDY TEAM Randomisation charge per requirement includes allocation of subject number and may be up to 60 mins for oncology studies. Line item is charged per dial in requirement where applicable. Note some studies may require dual dial-in e.g. Pharmacy then clinical staff. Time shown should be adjust to reflect average time required for randomisation. Review of randomisation criteria after run-in period may also be required. 0 15 0
NIHR_PRC_016 Instructions/education for patient and/or care giver STUDY TEAM Explaining study procedures to patient and/or care giver, discussion around drug regimen and SAEs. 15 15 0
NIHR_PRC_017 Subject Questionnaire STUDY TEAM Variable depending on questionnaire required 0 30 0
NIHR_PRC_018 Review Questionnaire STUDY TEAM Variable depending on questionnaire completed 0 30 0
NIHR_PRC_019 Concomitant medication check (at screening) STUDY TEAM Complex PD drug regimes may require this procedure 5 15 0
NIHR_PRC_020 Concomitant medication check (on study) STUDY TEAM Complex PD drug regimes may require this procedure 0 5 0
NIHR_PRC_021 Prescription for study STUDY TEAM
5 15 0
NIHR_PRC_022 Administer study drug in clinic STUDY TEAM Variable time depending on study drug administration method required by the protocol. Time should include clinical preparation, administration of study drug and observation. 15 30 0
NIHR_PRC_023 Dispense diaries and instruct STUDY TEAM
0 15 0
NIHR_PRC_024 Collect and review diaries STUDY TEAM
0 15 0
NIHR_PRC_025 Drug accountability and compliance STUDY TEAM Clinical staff responsibility (should not be duplicated with Pharmacy) 0 10 0
NIHR_PRC_026 CRF/eCRF completion including data transfer and query resolution STUDY TEAM Variable time depending on amount and type of data collected per visit e.g. complex visit (e.g. Screening or End-of-Study), standard visit or simple visit (e.g. logging phone contact/survival).
A time per page to complete approach could be used to calculate actually time needed.
Clinicians are usually required to sign off (especially lab results and eCRFs) so clinical time should always be considered.
Time includes data query resolution time: calculation of time may require an assumption for the number of queries per patient
If required, time should be adjusted to include transfer of patient note information into a Case Report Form (CRF), Electronic Data Capture (EDC) system or and electronic CRF (eCRF) which may include
- transcribing into hospital notes and the hospital electronic patient system (if applicable) from one of the sources above
- transcribing and reporting of diaries, questionnaires, profiles and titrations.
15 60 0
NIHR_PRC_027 Review/reporting of patient AEs/SAEs STUDY TEAM Time allocated per AE/SAE so may require an assumption for the number of AE/SAE per patient or inclusion in the 'Additional Itemised Cost' section instead of 'Per Patient'.
Nurse time could be up to 30 for an oncology patient or other complex patient condition studies, which needs to be considered when assigning time.
5 30 0
NIHR_PRC_028 Handover to routine care (End of Trial) STUDY TEAM Time for patient study sign-off including letter to Patient's GP and/or handover to routine care. Includes time to confirm if patient completed the study as per the protocol (Y/N) and/or withdrawn (Y/N) 15 0 0
NIHR_PRC_029 Device calibration / alteration of mechanical device settings and monitoring STUDY TEAM When devices are used in patient care and integrated into trials, the settings need calibrating, monitoring and altering for the patient 0 40 0
NIHR_PRC_030 Monitoring on-site visits or risk/remote based monitoring communication STUDY TEAM Time can be allocated per patient visit which is monitored and is variable depending on duration of the study, requirements of visit and monitoring visit schedule. If inclusion of risk/remote based monitoring communication as an alternative to on-site visits, the monitoring plan should be consulted to ensure monitoring visit frequency and durations are appropriately included.
This may be also included in the 'Additional Itemised Cost' section if the monitoring visit frequency is not aligned with patient visits. Clinical time may also be needed for inclusion if requested. As a guidance, CRAs can monitor approximately 10 patient visits at each visit.
0 5 0
NIHR_PRC_031 Dissemination of study results to participants STUDY TEAM Investigator time to receive and read the Clinical Study Report (CSR) or synopsis and disseminate the results of the study to the study participants. 30 30 0
NIHR_PRC_033 Dispensing time for standard agent or IMP/NIMP (excluding use of IVR/IWR) PHARMACY Pharmacy Activity 0 70 0
NIHR_PRC_034 Aseptic dispensing agent time PHARMACY Pharmacy Activity 0 120 0
NIHR_PRC_035 Controlled drug - additional dispensing time PHARMACY Pharmacy Activity 0 75 0
NIHR_PRC_036 Advanced therapy - additional preparation time [where relevant] PHARMACY Pharmacy Activity 0 240 0
NIHR_PRC_037 Use of IVR/IWR system (only chargeable if performed by Pharmacy) PHARMACY Pharmacy Activity 0 16 0
NIHR_PRC_038 Pharmacy arrangement of IMP delivery or posting preparation time to the patient PHARMACY Pharmacy Activity 0 20 0
NIHR_PRC_039 Individual patient drug accountability time PHARMACY Pharmacy Activity 0 35 0
NIHR_PRC_040 Patient Eligibility Assessment STUDY TEAM Time taken to assess the patient against the inclusion, exclusion and medical history criteria for the study 30 0 0
NIHR_PRC_041 ECOG Status STUDY TEAM Time taken to assess the patient against the inclusion, exclusion and medical history criteria for the study 5 0 0
NIHR_PRC_042 Pulse Oximetry STUDY TEAM Time taken to carry out testing that measures your oxygen saturation level, or the oxygen levels in a recruits blood 0 5 0
NIHR_PRC_043 Reconsenting STUDY TEAM Time taken, if necessary, for subjects to reaffirm their decision to participate, to re-consent, or to sign or re-sign a document 15 15 0
NIHR_PRC_044 Monitoring visit (additional itemised cost only) STUDY TEAM Time taken for the study team to fully participate in a non-triggered monitoring visit by the trial Sponsor/ CRO 60 240 0

Sheet 2: Investigations

Workbook content:



This tariff has been created to assist both Industry and NHS partners to create consistent and meaningful costings for Industry sponsored research within the NHS.








Values within this tariff do not include the relevant labour time required by research staff to initiate, carry out or report on the activity described.








Please note that all values included below are guidelines and may require adaptaion due to complexity, additional staff involvement or eternal third party contracts.








All values include an indirect cost and therefore only need the addition of capacity building and the local PbR MFF from the Industry Costing Tool to produce valid figures.








All entries contain the following:













●       Grantplan or NIHR Coding - Codes from the Industry Grantplan software or NIHR coding (for reference) where Grantplan coding is absent.








●       Activity Description - Brief Description of activity taking place








●       Specialty - Defined service support specialty that covers the activity (this may vary from one NHS organisation to another.








●       Notes - Whether the activity is a single investigation, an intervention with associated investigation or a unit cost activity at setup or during the project.








●       2022/23 Costs - The defined unitary cost for the activity including an indirect element













Please note that these are NHS costs only and do not represent costs provided by commercial or academic units. A degree of consideration will be required in order to cost any of these items in conjunction with external NHS SLAs contract to either of these entities.








All scanning costs below include a single report witin the unit cost. Additional reports should be requested individually from the reporting section of the tariff







Code Activity Description Specialty Notes 2022/23
92552 Pure tone audiometry (threshold); air only AUDIOLOGY Investigation £66
92553 Pure tone audiometry (threshold); air and bone AUDIOLOGY Investigation £66
92555 Speech audiometry threshold AUDIOLOGY Investigation £86
92556 Speech audiometry threshold; with speech recognition AUDIOLOGY Investigation £86
92557 Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined) AUDIOLOGY Investigation £122
92567 Tympanometry (impedance testing), tympanogram AUDIOLOGY Investigation £43
92579 Visual Reinforcement Audiometry (VRA) AUDIOLOGY Investigation £61
92582 Conditioning Play Audiometry (CPA) AUDIOLOGY Investigation £61
92625 Assessment of tinnitus (includes pitch, loudness matching, and making) AUDIOLOGY Investigation £58
71275 CT angiography, chest, without contrast , followed by contrast material and further sections, including image post-processing; MDCT; Multidetector CT: For report use code R1275; (CT Scan) CARDIOVASCULAR Investigation £351
72159 Magnetic resonance angiography, spinal canal, spine and contents (MRA), with or without contrast: Reporting code R2159. CARDIOVASCULAR Investigation £606
75705 Angiography, angiogram, spinal, selective, spine: Reporting code R5705. If applicable please include code 93539 CARDIOVASCULAR Investigation £2,034
75710 Angiography, angiogram, extremity, unilateral: Reporting code R5710. If applicable please include code 93539 CARDIOVASCULAR Investigation £2,034
75716 Angiography, angiogram, extremity, bilateral: Reporting code R5716. If applicable please include code 93539 CARDIOVASCULAR Investigation £2,034
75726 Angiography, visceral, selective or supraselective, (with or without flush aortogram), radiological supervision and interpretation; For Interpretation and Report used code R5726 CARDIOVASCULAR Investigation £2,034
75736 Angiography, angiogram, pelvic, pelvis, selective or supraselective: Reporting code R5736. CARDIOVASCULAR Investigation £2,034
75741 Angiography, angiogram, pulmonary, unilateral, selective: Reporting code R5741. CARDIOVASCULAR Investigation £2,034
75743 Angiography, angiogram, pulmonary, bilateral, selective: Reporting code R5743. CARDIOVASCULAR Investigation £2,034
76825 Fetal Echocardiography, cardiovascular system; real time with image documentation (2D), with or without M-mode recording: Reporting code R6825. CARDIOVASCULAR Investigation £185
78445 Non-cardiac vascular flow imaging (ie, angiography, angiogram, venography): Reporting code R8445. CARDIOVASCULAR Investigation £784
78453 Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique): Reporting code R8453. CARDIOVASCULAR Investigation £650
78454 Myocardial perfusion imaging, multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection: Reporting code R8454. CARDIOVASCULAR Investigation £650
78472 Cardiac blood pool imaging, radionuclide ventriculography, left ventricular ejection fraction (LVEF) (RNV) (MUGA), single study at rest or stress: Reporting code R8472. CARDIOVASCULAR Investigation £458
78473 Cardiac blood pool imaging, radionuclide ventriculography, left ventricular ejection fraction (LVEF) (RNV) (MUGA), multiple studies at rest and stress: Reporting code R8473. CARDIOVASCULAR Investigation £458
92230 Fluorescein angioscopy, angiogram; unilateral: Includes interpretation and report CARDIOVASCULAR Investigation £784
93000 Electrocardiogram, routine ECG (EKG) with at least 12 leads, 12 lead ECG, 12-lead ECG: Includes tracing, interpretation and report CARDIOVASCULAR Investigation £34
93005 Electrocardiogram, routine ECG (EKG) with at least 12 leads, 12 lead ECG, 12-lead ECG: Tracing only CARDIOVASCULAR Investigation £22
93010 Electrocardiogram, routine ECG (EKG) with at least 12 leads, 12 lead ECG, 12-lead ECG: Interpretation and report only CARDIOVASCULAR Investigation £34
93015 Cardiovascular stress test using treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress (ETT); with physician supervision, interpretation and report CARDIOVASCULAR Investigation £241
93016 Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress CARDIOVASCULAR Investigation £241
93040 Rhythm electrocardiogram, one to three leads (ECG) (EKG); with tracing, interpretation and report CARDIOVASCULAR Investigation £34
93224 External electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; includes recording, scanning analysis with report, physician review and interpretation CARDIOVASCULAR Investigation £34
93225 Electrocardiographic monitoring for up to 48 hours by continuous original ECG waveform recording and storage, holter monitoring; recording which includes hook-up, recording, and disconnection CARDIOVASCULAR Investigation £168
93226 Electrocardiographic monitoring for up to 48 hours by continuous original ECG waveform recording and storage, holter monitoring; scanning analysis with report, up to 48 hours CARDIOVASCULAR Investigation £168
93227 Electrocardiographic monitoring for up to 48 hours by continuous original ECG waveform recording and storage, holter monitoring; physician review and interpretation only, up to 48 hours CARDIOVASCULAR Investigation £168
93278 Signal-averaged electrocardiography (SAECG), with or without ECG CARDIOVASCULAR Investigation £30
93306 Echocardiography, transthoracic, real-time with image documentation (2D) , includes M-mode recording with spectral or color flow Doppler echocardiography: Reporting code R3306 CARDIOVASCULAR Investigation £221
93307 Echocardiography, transthoracic, real-time with image documentation (2D) with or without M-mode recording; complete: Reporting code R3307. CARDIOVASCULAR Investigation £221
93308 Echocardiography, transthoracic, real-time with image documentation (2D) with or without M-mode recording; follow-up or limited study: Reporting code R3308. CARDIOVASCULAR Investigation £221
93312 Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement under sedation, image acquisition, interpretation and report CARDIOVASCULAR Investigation £694
93320 Doppler echocardiography, pulsed wave and/or continuous wave with spectral display; complete CARDIOVASCULAR Investigation £221
93321 Doppler echocardiography, pulsed wave and/or continuous wave with spectral display; follow-up or limited study CARDIOVASCULAR Investigation £221
93325 Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) CARDIOVASCULAR Investigation £221
93350 Echocardiography, transthoracic, real-time with image documentation (2D, +/- M-mode recording), during rest and cardiovascular stress test , for interpretation and report please use code R3350. CARDIOVASCULAR Investigation £221
93464 Physiological exercise study (eg, bicycle or arm ergometry) including assessing hemodynamic measurements before and after moderate sedation: Reporting code R3464 CARDIOVASCULAR Investigation £241
93660 Evaluation of cardiovascular function with tilt table evaluation, with continuous ECG monitoring and intermittent blood pressure monitoring with or without pharmacological intervention CARDIOVASCULAR Investigation £597
93662 Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation ; Reporting code R3662. CARDIOVASCULAR Investigation £185
94620 Pulmonary stress testing; simple (eg, prolonged exercise test for bronchospasm with pre- and post-spirometry): Reporting code R4620. CARDIOVASCULAR Investigation £309
94621 Pulmonary stress testing; complex including measurements of CO2 production, O2 uptake and electrocardiographic recordings: Reporting code R4621. CARDIOVASCULAR Investigation £309
NIHR_INV_004 Insertion of Sheath Radial CARDIOVASCULAR Intervention includes Investigation (where applicable) £967
NIHR_INV_005 Insertion of Sheath (Femoral) - Short CARDIOVASCULAR Intervention includes Investigation (where applicable) £951
NIHR_INV_006 Insertion of Sheath (Femoral) - Long CARDIOVASCULAR Intervention includes Investigation (where applicable) £987
NIHR_INV_007 Insertion of PCI wire CARDIOVASCULAR Intervention includes Investigation (where applicable) £1,006
NIHR_INV_008 Insertion of OCT Catheter CARDIOVASCULAR Intervention includes Investigation (where applicable) £1,833
NIHR_INV_009 IVUS CARDIOVASCULAR Investigation £193
NIHR_INV_010 24 Hour Ambulatory ECG Monitor CARDIOVASCULAR Investigation £126
NIHR_INV_011 48 Hour Ambulatory ECG Monitor CARDIOVASCULAR Investigation £104
NIHR_INV_012 Tape Analysis CARDIOVASCULAR Investigation £244
NIHR_INV_013 24 Hour Blood Pressure Monitor CARDIOVASCULAR Investigation £61
NIHR_INV_014 Echocardiogram with Doppler CARDIOVASCULAR Investigation £506
NIHR_INV_015 Metabolic Exercise Test CARDIOVASCULAR Investigation £462
NIHR_INV_016 Reveal Interrogation CARDIOVASCULAR Investigation £244
NIHR_INV_018 Pacemaker Check CARDIOVASCULAR Investigation £133
NIHR_INV_019 ICD Check CARDIOVASCULAR Investigation £133
NIHR_INV_020 Arjalamine Test CARDIOVASCULAR Investigation £395
NIHR_INV_022 Stress Echo CARDIOVASCULAR Investigation £400
NIHR_INV_023 Contrast Echo CARDIOVASCULAR Investigation £891
NIHR_INV_024 Biventricular Pacemaker Assessments and Optimisations via Echocardiogram CARDIOVASCULAR Investigation £891
T1206 Electrocardiogram, 12 Lead ECG - Triplicate; Includes tracing, interpretation and report CARDIOVASCULAR Investigation £34
T1207 Electrocardiogram, 12 Lead ECG - Triplicate; tracing only; Reporting code RT207 CARDIOVASCULAR Investigation £30
T5744 Angiography, angiogram, complete coronary: Reporting code RT744. (Formerly QuintilesIMS code 75744) CARDIOVASCULAR Investigation £784
NIHR_INV_084 Cone Beam CT DENTAL RADIOLOGY Investigation £169
NIHR_INV_001 Daily Facility Charge - Per Day (PAEDIATRIC) GENERAL Setup or Additional Itemised Activity £620
NIHR_INV_002 Overnight Facility Charge, Simple (e.g. regular ward room) - Per Night (PAEDIATRIC) GENERAL Setup or Additional Itemised Activity £871
NIHR_INV_003 Overnight Facility Charge, High (e.g. high dependancy unit, CCU, psychiatric medium secure unit) - Per Night GENERAL Setup or Additional Itemised Activity £1,792
NP009 Daily Facility Charge - Per Day (ADULT) GENERAL Setup or Additional Itemised Activity £215
NP010 Overnight Facility Charge, Simple (e.g. regular ward room) - Per Night (ADULT) GENERAL Setup or Additional Itemised Activity £427
NP013 Copies of Diagnostic Films, Simple (e.g. x-rays) - Per Copy GENERAL Setup or Additional Itemised Activity £56
NP014 Copies of Diagnostic Films, Complex (e.g. high technology, video recordings, compact discs, CDs) - Per Copy GENERAL Setup or Additional Itemised Activity £56
NP016 Overnight Facility Charge, Complex (e.g. intensive care unit, telemetry unit, psychiatric hospital) - Per Night GENERAL Setup or Additional Itemised Activity £3,096
OC057 Electronic Lab Data Transfer - Per Transfer GENERAL Setup or Additional Itemised Activity £29
OC059 Lab Set-Up Costs, Laboratory Set-Up Costs - Per Lab GENERAL Setup or Additional Itemised Activity £276
81161 DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis and duplication analysis, if performed GENETICS Investigation £389
81200 ASPA (aspartoacylase) (eg, Canavan disease) gene analysis, common variants (eg, E285A, Y231X) GENETICS Investigation £389
81201 APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; full gene sequence GENETICS Investigation £389
81202 APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; known familial variants GENETICS Investigation £389
81203 APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; duplication/deletion variants GENETICS Investigation £389
81205 BCKDHB (branched-chain keto acid dehydrogenase E1,beta polypeptide) (eg, Maple syrup urine disease) gene analysis, common variants (eg, R183P, G278S, E422X) GENETICS Investigation £389
81206 BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative GENETICS Investigation £389
81207 BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitative GENETICS Investigation £389
81208 BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitative GENETICS Investigation £389
81209 BLM (Bloom syndrome, RecQ helicase-like) (eg, Bloom syndrome) gene analysis, 2281del6ins7 variant GENETICS Investigation £389
81210 BRAF (v-raf murine sarcoma viral oncogene homolog B1) (eg, colon cancer), gene analysis, V600E variant GENETICS Investigation £389
81211 BRCA1, BRCA2 gene analysis; full sequence analysis and common duplication/deletion variants in BRCA1 GENETICS Investigation £389
81212 BRCA1, BRCA2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis;185delAG, 5385insC, 6174delT variants GENETICS Investigation £389
81213 BRCA1, BRCA2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; uncommon duplication/deletion variants GENETICS Investigation £389
81214 BRCA1 gene analysis; full sequence analysis and common duplication/deletion variants GENETICS Investigation £389
81215 BRCA1 (breast cancer 1) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant GENETICS Investigation £389
81216 BRCA2 (breast cancer 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis GENETICS Investigation £389
81217 BRCA2 (breast cancer 2) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant GENETICS Investigation £389
81220 CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; common variants (eg, ACMG/ACOG guidelines) GENETICS Investigation £389
81221 CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variants GENETICS Investigation £389
81222 CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; duplication/deletion variants GENETICS Investigation £389
81224 CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; intron 8 poly-T analysis (eg, male infertility) GENETICS Investigation £389
81225 CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *8, *17) GENETICS Investigation £389
81226 CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *9, *10, *17, *19, *29, *35, *41, *1XN, *2XN, *4XN) GENETICS Investigation £389
81227 CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *5, *6) GENETICS Investigation £389
81228 Cytogenomic constitutional microarray analysis; interrogation of genomic regions for copy number variants GENETICS Investigation £389
81229 Cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants for chromosomal abnormalities GENETICS Investigation £389
81235 EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G749A, G719S, L861Q) (formerly code T0910) GENETICS Investigation £389
81241 F5 (coagulation Factor V) (eg, hereditary hypercoagulability) gene analysis, Leiden variant GENETICS Investigation £389
81242 FANCC (Fanconi anemia, complementation group C) (eg, Fanconi anemia, type C) gene analysis, common variant (eg, IVS4 4A>T) GENETICS Investigation £389
81243 FMR1 (Fragile X mental retardation 1) (eg, fragile X mental retardation) gene analysis; evaluation to detect abnormal (eg, expanded) alleles GENETICS Investigation £389
81244 FMR1 (Fragile X mental retardation 1) (eg, fragile X mental retardation) gene analysis; characterization of alleles (eg, expanded size and methylation status) GENETICS Investigation £389
81251 GBA (glucosidase, beta, acid) (eg, Gaucher disease) gene analysis, common variants (eg, N370S, 84GG, L444P, IVS2 1G>A) GENETICS Investigation £389
81255 HEXA (hexosaminidase A [alpha polypeptide]) (eg, Tay-Sachs disease) gene analysis, common variants (eg, 1278insTATC, 1421 1G>C, G269S) GENETICS Investigation £389
81256 HFE (hemochromatosis) (eg, hereditary hemochromatosis) gene analysis, common variants (eg, C282Y, H63D) GENETICS Investigation £389
81257 HBA1/HBA2 gene analysis, for common deletions or variant GENETICS Investigation £389
81261 IGH@ gene rearrangement analysis to detect abnormal clonal populations; amplified methodology GENETICS Investigation £389
81262 IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); direct probe methodology (eg, Southern blot) GENETICS Investigation £389
81263 IGH@ (Immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, B-cell), variable region somatic mutation analysis GENETICS Investigation £389
81264 IGK@ (Immunoglobulin kappa light chain locus) (eg, leukemia and lymphoma, B-cell), gene rearrangement analysis, evaluation to detect abnormal clonal population(s) GENETICS Investigation £389
81265 Comparative analysis using Short Tandem Repeat (STR) markers; patient and comparative specimen GENETICS Investigation £389
81266 Comparative analysis using Short Tandem Repeat (STR) markers; each additional specimen GENETICS Investigation £389
81267 Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selection GENETICS Investigation £389
81268 Chimerism analysis, post transplantation specimen, includes comparison to previously performed baseline analyses; with cell selection each cell type GENETICS Investigation £389
81275 KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) (eg, carcinoma) gene analysis, variants in codons 12 and 13 GENETICS Investigation £389
81276 KRAS (Kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; additional variant(s) (eg, codon 61, codon 146) GENETICS Investigation £389
81290 MCOLN1 (mucolipin 1) (eg, Mucolipidosis, type IV) gene analysis, common variants (eg, IVS3-2A>G, del6.4kb) GENETICS Investigation £389
81291 MTHFR (5,10-methylenetetrahydrofolate reductase) (eg, hereditary hypercoagulability) gene analysis, common variants (eg, 677T, 1298C) GENETICS Investigation £389
81292 MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81293 MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants GENETICS Investigation £389
81294 MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants GENETICS Investigation £389
81295 MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81296 MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants GENETICS Investigation £389
81297 MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants GENETICS Investigation £389
81298 MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary nonpolyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81299 MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary nonpolyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants GENETICS Investigation £389
81300 MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary nonpolyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants GENETICS Investigation £389
81301 Microsatellite instability analysis of markers for mismatch repair deficiency, includes comparison of neoplastic and normal tissue, if performed GENETICS Investigation £389
81302 MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81303 MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; known familial variant GENETICS Investigation £389
81304 MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; duplication/deletion variants GENETICS Investigation £389
81310 NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variants GENETICS Investigation £389
81311 NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61) GENETICS Investigation £389
81313 PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer) GENETICS Investigation £389
81315 PML/RARalpha, (t(15;17)), (promyelocytic leukemia/ retinoic acid receptor alpha) translocation analysis; common breakpoints, qualitative or quantitative GENETICS Investigation £389
81316 PML/RARalpha, (t(15;17)), (promyelocytic leukemia/ retinoic acid receptor alpha) translocation analysis; single breakpoint, qualitative or quantitative GENETICS Investigation £389
81317 PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81318 PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants GENETICS Investigation £389
81319 PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants GENETICS Investigation £389
81321 PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; full sequence analysis GENETICS Investigation £389
81322 PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; known familial variant GENETICS Investigation £389
81323 PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; duplication/deletion variant GENETICS Investigation £389
81324 PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysis GENETICS Investigation £389
81325 PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysis GENETICS Investigation £389
81326 PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; known familial variant GENETICS Investigation £389
81327 Molecular PathologyRevisions have been made to Molecular Pathology Guidelines including the deletion of three Tier 1 Molecular Pathology CPT codes (81280-81282) and the addition of a new Tier 1 CPT c GENETICS Investigation £389
81330 SMPD1(sphingomyelin phosphodiesterase 1, acid lysosomal) (eg, Niemann-Pick disease, Type A) gene analysis, common variants (eg, R496L, L302P, fsP330) GENETICS Investigation £389
81331 SNRPN/UBE3A (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A) (eg, Prader-Willi syndrome and/or Angelman syndrome), methylation analysis GENETICS Investigation £389
81332 SERPINA1 (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) (eg, alpha-1-antitrypsin deficiency), gene analysis, common variants (eg, *S and *Z) GENETICS Investigation £389
81340 TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (eg, polymerase chain reaction) GENETICS Investigation £389
81341 TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using direct probe methodology (eg, Southern blot) GENETICS Investigation £389
81342 TRG@ (T cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s) GENETICS Investigation £389
81350 UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) (eg, irinotecan metabolism), gene analysis, common variants (eg, *28, *36, *37) GENETICS Investigation £389
81355 VKORC1 (vitamin K epoxide reductase complex, subunit 1) (eg, warfarin metabolism), gene analysis, common variants (eg, -1639/3673) GENETICS Investigation £389
81370 HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 GENETICS Investigation £389
81371 HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, and -DRB1/3/4/5 (eg, verification typing) GENETICS Investigation £389
81372 HLA Class I typing, low resolution (eg, antigen equivalents); complete (ie, HLA-A, -B, and -C) GENETICS Investigation £389
81373 HLA Class I typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-A, -B, or -C), each GENETICS Investigation £389
81374 HLA Class I typing, low resolution (eg, antigen equivalents); one antigen equivalent (eg, B*27), each GENETICS Investigation £389
81375 HLA Class II typing, low resolution (eg, antigen equivalents); HLADRB1/3/4/5 and -DQB1 GENETICS Investigation £389
81376 HLA Class II typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-DRB1 /3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each GENETICS Investigation £389
81377 HLA Class II typing, low resolution (eg, antigen equivalents); one antigen equivalent, each GENETICS Investigation £389
81378 HLA Class I and II typing, high resolution (ie, alleles or allele groups), HLAA, -B, -C, and -DRB1 GENETICS Investigation £389
81379 HLA Class I typing, high resolution (ie, alleles or allele groups); complete (ie, HLA-A, -B, and -C) GENETICS Investigation £389
81380 HLA Class I typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-A, -B, or -C), each GENETICS Investigation £389
81381 HLA Class I typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, B*57:01P), each GENETICS Investigation £389
81382 HLA Class II typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-DRB1, -DRB3, -DRB4, -DRB5, -DQB1, -DQA1, -DPB1, or -DPA1), each GENETICS Investigation £389
81383 HLA Class II typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, HLA-DQB1*06:02P), each GENETICS Investigation £389
81400 Molecular pathology procedure, Level 1 (eg, identification of single germline variant [eg, SNP] by techniques such as restriction enzyme digestion or melt curve analysis) GENETICS Investigation £389
81402 Molecular pathology procedure, Level 3 (eg, >10 SNPs, 2-10 methylated variants, or 2-10 somatic variants immunoglobulin and T-cell receptor gene rearrangements) GENETICS Investigation £389
81400-01 ACADM (acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD), K304E variant New molecular pathology code benchmarks pending increased market usage. GENETICS Investigation £389
81400-02 ACE (angiotensin converting enzyme), insertion/deletion variant. New molecular pathology code benchmarks pending increased market usage. GENETICS Investigation £389
81400-03 AGTR1 (angiotensin II receptor, type 1) (eg, essential hypertension),1166A>C variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-04 BCKDHA (branched chain keto acid dehydrogenase E1, alpha polypeptide), Y438N variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-05 CCR5 (chemokine C-C motif receptor 5), 32-bpdeletion mutation/794 825del32 deletion. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-06 CLRN1 (clarin 1) (eg, Usher syndrome, type 3), N48K variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-07 DPYD (dihydropyrimidine dehydrogenase), IVS14+1G>A variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-08 F2 (coagulation factor 2) (eg, hereditary hypercoagulability), 1199G>Avariant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-09 F5 (coagulation factor V) (eg, hereditary hypercoagulability), HR2 variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-10 F13B (coagulation factor XIII, B polypeptide), V34L variant . New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-13 FGFR1 (fibroblast growth factor receptor 1), P252R variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-14 FGFR3 (fibroblast growth factor receptor 3) (eg, Muenke syndrome),P250R variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-15 FKTN (Fukutin) retrotransposon insertion variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-25 IL28B (interleukin 28B [interferon, lambda 3]) (eg, drug response), rs12979860 variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-26 IVD (isovaleryl-CoA dehydrogenase) (eg, isovaleric acidemia), A282Vvariant GENETICS Investigation £389
81400-28 NEB (nebulin) (eg, nemaline myopathy 2), exon 55 deletion variant GENETICS Investigation £389
81400-29 PCDH15 (protocadherin-related 15) (eg, Usher syndrome type 1F), R245X variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-30 SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1), 4G variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-31 SHOC2 (soc-2 suppressor of clear homolog) (eg, Noonan-like syndromewith loose anagen hair), S2G variant GENETICS Investigation £389
81400-32 SLCO1B1 (solute carrier organic anion transporter family, member 1B1), V174A variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81400-33 SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscularatrophy), exon 7 deletion GENETICS Investigation £389
81400-34 SRY (sex determining region Y) (eg, 46,XX testicular disorder of sexdevelopment, gonadal dysgenesis), gene analysis GENETICS Investigation £389
81400-35 TOR1A (torsin family 1, member A [torsin A])(eg, early-onset primarydystonia [DYT1]), 907_909delGAG (904_906delGAG) variant. New molecular pathology code benchmarks pending increased market usage. . GENETICS Investigation £389
81401-01 ABCC8 (ATP-binding cassette, sub-family C CFTR/MRP], member 8) common variants GENETICS Investigation £389
81401-03 ACADM (acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD) (eg, medium chain acyl dehydrogenase deficiency), commons variants (eg, K304E, Y42H). GENETICS Investigation £389
81401-05 AFF2 (AF4/FMR2 family, member 2 [FMR2]) (eg, fragile X mental retardation 2 [FRAXE]), evaluation to detect abnormal (eg, expanded) alleles GENETICS Investigation £389
81401-07 APOE (apolipoprotein E) (eg, hyperlipoproteinemia type III, cardiovascular disease, Alzheimer disease), common variants (eg, *2, *3, *4) GENETICS Investigation £389
81401-08 AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), characterization of alleles (eg, expanded size or methylation status) GENETICS Investigation £389
81401-09 ATN1 (atrophin 1) (eg, dentatorubral-pallidoluysian atrophy),evaluation to detect abnormal (eg, expanded) alleles. GENETICS Investigation £389
81401-10 ATXN1 (ataxin 1) (eg, spinocerebellar ataxia), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-11 ATXN2 (ataxin 2) (eg, spinocerebellar ataxia), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-12 ATXN3 (ataxin 3) (eg, spinocerebellar ataxia, Machado-Joseph disease), evaluation to detect abnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-13 ATXN7 (ataxin 7) (eg, spinocerebellar ataxia), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-14 ATXN8OS (ATXN8 opposite strand [non-protein coding]) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg,expanded) alleles. GENETICS Investigation £389
81401-15 ATXN10 (ataxin 10) (eg, spinocerebellar ataxia), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-16 CACNA1A (calcium channel, voltage-dependent, P/Q type, alpha1A subunit) (eg, spinocerebellar ataxia), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-17 CBFB/MYH11 (inv(16)) (eg, acute myeloid leukemia), qualitative,and quantitative, if performed. GENETICS Investigation £389
81401-18 CBS (cystathionine-beta-synthase) (eg, homocystinuria, cystathioninebeta-synthase deficiency), common variants (eg, I278T, G307S). GENETICS Investigation £389
81401-19 CCND1/IGH (BCL1/IgH, t(11;14)) (eg, mantle cell lymphoma)translocation analysis, major breakpoint, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-20 CFH/ARMS2 (complement factor H/age-related maculopathysusceptibility 2) (eg, macular degeneration), common variants(eg, Y402H [CFH], A69S [ARMS2]). GENETICS Investigation £389
81401-21 CNBP (CCHC-type zinc finger, nucleic acid binding protein)(eg, myotonic dystrophy type 2), evaluation to detectabnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-22 CSTB (cystatin B [stefin B]) (eg, Unverricht-Lundborg disease),evaluation to detect abnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-23 CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) (eg, drug metabolism), common variants (eg, *2, *3, *4, *5, *6) GENETICS Investigation £389
81401-24 CYP3A5 (cytochrome P450, family 3, subfamily A, polypeptide 5) (eg,drug metabolism), common variants (eg, *2, *3, *4, *5, *6). GENETICS Investigation £389
81401-26 E2A/PBX1 (t(1;19)) (eg, acute lymphocytic leukemia), translocationanalysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-27 EML4/ALK (inv(2)) (eg, non-small cell lung cancer), translocation or inversion analysis. GENETICS Investigation £389
81401-28 ETV6/NTRK3 (t(12;15)) (eg, congenital/infantile fibrosarcoma), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-29 ETV6/RUNX1 (t(12;21)) (eg, acute lymphocytic leukemia), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-30 EWSR1/ATF1 (t(12;22)) (eg, clear cell sarcoma), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-31 EWSR1/ERG (t(21;22)) (eg, Ewing sarcoma/peripheral neuroectodermaltumor), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-32 EWSR1/FLI1 (t(11;22)) (eg, Ewing sarcoma/peripheral neuroectodermaltumor), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-33 EWSR1/WT1 (t(11;22)) (eg, Ewing sarcoma/peripheral neuroectodermal tumor desmoplastic small round cell tumor), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-34 F11 (coagulation factor XI) (eg, coagulation disorder), common variants(eg, E117X [Type II], F283L [Type III], IVS14del14, and IVS14+1G>A[Type I]). GENETICS Investigation £389
81401-35 FGFR3 (fibroblast growth factor receptor 3) (eg, achondroplasia, hypochondroplasia), common variants (eg, 1138G>A, 1138G>C,1620C>A, 1620C>G). GENETICS Investigation £389
81401-36 FIP1L1/PDGFRA (del[4q12]) (eg, imatinib-sensitive chronic eosinophilicleukemia), qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-37 FLG (filaggrin) (eg, icthyosis vulgaris), common variants (eg, R501X, 2282del4, R2447X, S3247X, 3702delG). GENETICS Investigation £389
81401-38 FOXO1/PAX3 t(12;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed GENETICS Investigation £389
81401-39 FOXO1/PAX7 (t(21;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed GENETICS Investigation £389
81401-40 FXN (frataxin) (eg, Friedreich ataxia), evaluation to detect abnormal(expanded) alleles. GENETICS Investigation £389
81401-41 FUS/DDIT3 (t(12;16)) (eg, myxoid liposarcoma), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-42 GALC (galactosylceramidase) (eg, Krabbe disease), common variants (eg,c.857G>A, 30-kb deletion) GENETICS Investigation £389
81401-43 GALT (galactose-1-phosphate uridylyltransferase) (eg, galactosemia), common variants (eg, Q188R, S135L, K285N, T138M, L195P, Y209C, IVS2-2A>G, P171S, del5kb, N314D, L218L/N314D) GENETICS Investigation £389
81401-44 GNAQ (guanine nucleotide-binding protein G[q] subunit alpha)(eg, uveal melanoma), common variants (eg, R183, Q209) . GENETICS Investigation £389
81401-45 GALT (galactose-1-phosphate uridylyltransferase) (eg, galactosemia),common variants (eg, Q188R, S135L, K285N, T138M, L195P, Y209C, IVS2-2A>G, P171S, del5kb, N314D, L218L/N314D). GENETICS Investigation £389
81401-46 GNAQ (guanine nucleotide-binding protein G[q] subunit alpha)(eg, uveal melanoma), common variants (eg, R183, Q209). GENETICS Investigation £389
81401-47 H19 (imprinted maternally expressed transcript [non-protein coding])(eg, Beckwith-Wiedemann syndrome), methylation analysis. GENETICS Investigation £389
81401-48 HBB (hemoglobin, beta) (eg, sickle cell anemia, hemoglobin C,hemoglobin E), common variants (eg, HbS, HbC, HbE) GENETICS Investigation £389
81401-49 HTT (huntingtin) (eg, Huntington disease), evaluation to detect abnormal(eg, expanded) alleles GENETICS Investigation £389
81401-50 KCNQ1OT1 (KCNQ1 overlapping transcript 1 [non-protein coding]) (eg, Beckwith-Wiedemann syndrome), methylation analysis. GENETICS Investigation £389
81401-52 ont. MED12 (mediator complex subunit 12) (eg, FG syndrome type 1, Lujansyndrome), common variants (eg, R961W, N1007S). GENETICS Investigation £389
81401-53 MEG3/DLK1 (maternally expressed 3 [non-protein coding]/delta-like 1homolog [Drosophila]) (eg,intrauterine growth retardation), methylation analysis. GENETICS Investigation £389
81401-54 MLL/AFF1 (t(4;11)) (eg, acute lymphoblastic leukemia), translocationanalysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-55 MLL/MLLT3 (t(9;11)) (eg, acute myeloid leukemia), translocationanalysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-56 MT-RNR1 (mitochondrially encoded 12S RNA) (eg, nonsyndromichearing loss), common variants (eg, m.1555A>G, m.1494C>T). GENETICS Investigation £389
81401-57 MUTYH (mutY homolog [E. coli]) (eg, MYH-associated polyposis),common variants (eg, Y165C, G382D). GENETICS Investigation £389
81401-58 MT-ATP6 (mitochondrially encoded ATP synthase 6) (eg, neuropathy with ataxia and retinitis pigmentosa [NARP], Leigh syndrome), commonvariants (eg, m.8993T>G, m.8993T>C). GENETICS Investigation £389
81401-59 MT-ND4, MT-ND6 (mitochondrially encoded NADH dehydrogenase4, mitochondrially encoded NADH dehydrogenase 6) common variants GENETICS Investigation £389
81401-60 MT-TK (mitochondrially encoded tRNA lysine) (eg, myoclonic epilepsywith ragged-red fibers [MERRF]), common variants (eg, m.8344A>G,m.8356T>C). GENETICS Investigation £389
81401-61 MT-TL1 (mitochondrially encoded tRNA leucine 1 [UUA/G]) (eg, diabetesand hearing loss), common variants (eg, m.3243A>G, m.14709 T>C). GENETICS Investigation £389
81401-62 MT-ND5 (mitochondrially encoded tRNA leucine 1 [UUA/G],mitochondrially encoded NADH dehydrogenase 5) mitochondrial encephalopathy with lactic acidosis and stroke-like episodes [MELAS]),common variants GENETICS Investigation £389
81401-63 MT-TS1, MT-RNR1 (mitochondrially encoded tRNA serine 1 [UCN],mitochondrially encoded 12S RNA) ,common variants GENETICS Investigation £389
81401-64 NOD2 (nucleotide-binding oligomerization domaincontaining 2) (eg, Crohn’s disease, Blau syndrome),common variants (eg, SNP 8, SNP 12, SNP 13). GENETICS Investigation £389
81401-65 NPM1/ALK (t(2;5)) (eg, anaplastic large cell lymphoma),translocation analysis. GENETICS Investigation £389
81401-66 PABPN1 (poly[A] binding protein, nuclear 1) (eg, oculopharyngealmuscular dystrophy), evaluation to detect abnormal (eg, expanded) alleles. GENETICS Investigation £389
81401-68 PPP2R2B (protein phosphatase 2, regulatory subunit B, beta) (eg,spinocerebellar ataxia), evaluation to detect abnormal(eg, expanded) alleles . GENETICS Investigation £389
81401-69 PRSS1 (protease, serine, 1 [trypsin 1]) (eg, hereditary pancreatitis),common variants (eg, N29I, A16V,R122H) GENETICS Investigation £389
81401-70 PYGM (phosphorylase, glycogen, muscle) (eg, glycogen storage diseasetype V, McArdle disease), common variants (eg, R50X, G205S). GENETICS Investigation £389
81401-71 RUNX1/RUNX1T1 (t(8;21)) (eg, acute myeloid leukemia) translocationanalysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-72 SEPT9 (Septin 9) (eg, colon cancer), methylation analysis. GENETICS Investigation £389
81401-73 SMN1/SMN2 (survival of motor neuron 1, telomeric/survival of motorneuron 2, centromeric) (eg,spinal muscular atrophy), dosage analysis (eg,carrier testing). GENETICS Investigation £389
81401-74 SS18/SSX1 (t(X;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-75 SS18/SSX2 (t(X;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed. GENETICS Investigation £389
81401-76 TBP (TATA box binding protein) (eg, spinocerebellar ataxia), evaluation todetect abnormal (eg, expanded) alleles . GENETICS Investigation £389
81401-77 TPMT (thiopurine S-methyltransferase) (eg, drug metabolism), common variants (eg, *2, *3) GENETICS Investigation £389
81401-78 TYMS (thymidylate synthetase) (eg, 5-fluorouracil/5-FU drugmetabolism), tandem repeat variant. GENETICS Investigation £389
81401-79 VWF (von Willebrand factor) (eg, von Willebrand disease type 2N), common variants (eg, T791M, R816W, R854Q) GENETICS Investigation £389
81402-01 Chromosome 18q- (eg, D18S55, D18S58, D18S61, D18S64, and D18S69)(eg, colon cancer), allelic imbalance assessment (ie, loss of heterozygosity). Please reference general code 81402. GENETICS Investigation £389
81402-02 COL1A1/PDGFB (t(17;22)) (eg, dermatofibrosarcoma protuberans), translocation analysis, multiple breakpoints, qualitative, and quantitative, if performed. Please reference general code 81402. GENETICS Investigation £389
81402-03 CYP21A2 (cytochrome P450, family 21, subfamily A, polypeptide 2), common variants GENETICS Investigation £389
81402-05 IGH@/BCL2 (t(14;18)) translocation analysis; major breakpoint region (MBR) and minor cluster region (mcr)breakpoints, qualitative or quantitative. Please reference general code 81402. GENETICS Investigation £389
81402-06 KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, mastocytosis), common variants (eg, D816V, D816Y, D816F) GENETICS Investigation £389
81402-07 MEFV (Mediterranean fever) (eg, familial Mediterranean fever),common variants (eg, E148Q, P369S,F479L, M680I, I692del, M694V, M694I, K695R, V726A, A744S, R761H). Please reference general code 81402. GENETICS Investigation £389
81402-08 MPL (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, TPOR) (eg,myeloproliferative disorder), common variants (eg,W515A, W515K, W515L, W515R). Please reference general code 81402. GENETICS Investigation £389
81402-09 TRD@ (T cell antigen receptor, delta) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population. Please reference general code 81402. GENETICS Investigation £389
81402-10 Uniparental disomy (UPD) (eg, Russell-Silver syndrome, PraderWilli/Angelman syndrome), short tandem repeat (STR) analysis GENETICS Investigation £389
81403-03 ARX (aristaless related homeobox) (eg, X-linked lissencephaly with ambiguous genitalia, X-linked mental retardation), duplication/deletionanalysis GENETICS Investigation £389
81403-05 CEL (carboxyl ester lipase [bile salt-stimulated lipase]), targeted sequence analysis ofexon 11 GENETICS Investigation £389
81403-06 CTNNB1 (catenin [cadherin-associated protein], beta 1, 88kDa) (eg, desmoid tumors), targeted sequence analysis (eg, exon 3). Please reference general code 81403. GENETICS Investigation £389
81403-07 DAZ/SRY (deleted in azoospermia and sex determining region Y)(eg, male infertility), common deletions(eg, AZFa, AZFb, AZFc, AZFd). Please reference general code 81403. GENETICS Investigation £389
81403-09 EPCAM (epithelial cell adhesion molecule) (eg, Lynch syndrome), duplication/deletion analysis GENETICS Investigation £389
81403-10 F8 (coagulation factor VIII) (eg, hemophilia A), inversion analysis, intron 1and intron 22A GENETICS Investigation £389
81403-11 F12 (coagulation factor XII [Hageman factor]) (eg, angioedema, hereditary, type III; factorXII deficiency), targeted sequence analysis of exon 9. Please reference general code 81403. GENETICS Investigation £389
81403-12 FGFR3 (fibroblast growth factor receptor 3) (eg, isolated craniosynostosis), targeted sequence analysis (eg, exon 7) GENETICS Investigation £389
81403-14 HBB (hemoglobin, beta, beta-globin) (eg, beta thalassemia),duplication/deletion analysis GENETICS Investigation £389
81403-15 HRAS (v-Ha-ras Harvey ratsarcoma viral oncogene homolog) (eg,Costello syndrome), exon 2 Sequence. Please reference general code 81403. GENETICS Investigation £389
81403-16 IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma),common exon 4 variants (eg, R132H,R132C) GENETICS Investigation £389
81403-17 IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma),common exon 4 variants (eg,R140W, R172M). Please reference general code 81403. GENETICS Investigation £389
81403-19 KCNC3 (potassium voltage-gated channel, Shaw-related subfamily,member 3) (eg, spinocerebellar ataxia), targeted sequence analysis(eg, exon 2) . Please reference general code 81403. GENETICS Investigation £389
81403-22 Killer cell immunoglobulin-like receptor (KIR) genefamily (eg, hematopoietic stem cell transplantation), genotyping of KIR family genes. Please reference general code 81403. GENETICS Investigation £389
81403-24 KRAS (v-Ki-ras2 Kirsten ratsarcoma viral oncogene) (eg, carcinoma),gene analysis, variant(s) in exon 3 (eg, codon 61) GENETICS Investigation £389
81403-26 MICA (MHC class I polypeptide-related sequence A) (eg, solidorgan transplantation), common variants (eg, *001, *002). Please reference general code 81403. GENETICS Investigation £389
81403-27 MPL (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, TPOR) (eg,myeloproliferative disorder), exon 10 sequence GENETICS Investigation £389
81403-30 NDP (Norrie disease [pseudoglioma]) (eg, Norrie disease),duplication/deletion analysis. Please reference general code 81403. GENETICS Investigation £389
81403-32 PHOX2B (paired-like homeobox 2b) (eg, congenital central hypoventilation syndrome), duplication/deletionanalysis. Please reference general code 81403. GENETICS Investigation £389
81403-34 SH2D1A (SH2 domain containing 1A) (eg, X-linked lymphoproliferativesyndrome), duplication/deletion analysis. Please reference general code 81403. GENETICS Investigation £389
81403-35 SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscularatrophy), known familialsequence variant(s). Please reference general code 81403. GENETICS Investigation £389
81403-36 TWIST1 (twist homolog 1 [Drosophila]) (eg, Saethre-Chotzen syndrome), duplication/deletion analysis. Please reference general code 81403. GENETICS Investigation £389
81403-37 UBA1 (ubiquitin-like modifier activating enzyme 1) (eg, spinal muscularatrophy, X-linked), targeted sequence analysis(eg, exon 15) . Please reference general code 81403. GENETICS Investigation £389
81403-38 VHL (von Hippel-Lindau tumor suppressor) (eg, von Hippel-Lindau familial cancer syndrome), deletion/duplication analysis GENETICS Investigation £389
81403-39 VWF (von Willebrand factor) (eg, von Willebrand disease types 2A, 2B,2M), targeted sequence analysis (eg, exon 28). Please reference general code 81403. GENETICS Investigation £389
81404-01 ACADS (acyl-CoA dehydrogenase, C-2 to C-3 short chain) (eg, short chain acyl-CoA dehydrogenase deficiency), targeted sequence analysis (eg,exons 5 and 6). Please reference general code 81404. GENETICS Investigation £389
81404-02 AFF2 (AF4/FMR2 family, member 2 [FMR2]) (eg, fragile X mental retardation 2 [FRAXE]), characterization of alleles (eg, expandedsize and methylation status). Please reference general code 81404. GENETICS Investigation £389
81406-28 COL6A2 (collagen, type VI, alpha 2) (eg, collagen type VI-related disorders), duplication/deletion analysis GENETICS Investigation £389
81406-31 CREBBP (CREB binding protein) (eg, Rubinstein-Taybi syndrome),duplication/deletion analysis GENETICS Investigation £389
81406-32 Cytogenomic microarray analysis, neoplasia (eg, interrogation of copynumber microarray analysis) GENETICS Investigation £389
81406-45 F8 (coagulation factor VIII) (eg, hemophilia A), duplication/deletion analysis GENETICS Investigation £389
81406-68 JAG1 (jagged 1) (eg, Alagille syndrome), duplication/deletion analysis GENETICS Investigation £389
81406-95 OPA1 (optic atrophy 1) (eg, optic atrophy), duplication/deletion analysis GENETICS Investigation £389
81401 Molecular pathology procedure, Level 2 (eg, 2-10 SNPs, 1 methylated variant, or 1 somatic variant [using nonsequencing target variant analysis], or detection of a dynamic mutation disorder) IMMUNOLOGY or VIROLOGY Investigation £48
83516 Immunoassay for analyte other than infectious agent antibody or infectious agent antigen, qualitative or semiquantitative; multiple step method IMMUNOLOGY or VIROLOGY Investigation £29
83518 Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, single step method (eg, reagent strip) IMMUNOLOGY or VIROLOGY Investigation £29
83520 Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative use for all interleukin and cytokine analysis; thromin-Antithrombin Complex; Cystatin C IMMUNOLOGY or VIROLOGY Investigation £29
86021 Antibody identification; leukocyte antibodies IMMUNOLOGY or VIROLOGY Investigation £29
86022 Antibody identification; platelet antibodies IMMUNOLOGY or VIROLOGY Investigation £29
86023 Antibody identification; platelet associated immunoglobulin assay IMMUNOLOGY or VIROLOGY Investigation £29
86147 Cardiolipin (phospholipid) antibody, antiphospholipid, each Ig class IMMUNOLOGY or VIROLOGY Investigation £29
86200 Cyclic citrullinated peptide (CCP), antibody IMMUNOLOGY or VIROLOGY Investigation £29
86215 Deoxyribonuclease, antibody IMMUNOLOGY or VIROLOGY Investigation £29
86235 Extractable nuclear antigen, antibody to, any method (eg, nRNP, SS-A, SSA, SS-B, SSB, Sm, RNP, Sc170, J01); each antibody IMMUNOLOGY or VIROLOGY Investigation £29
86255 Fluorescent noninfectious agent antibody;anti-smooth muscle antibody (SMA) or anti-mitochondrial antibody; each antibody (e.g. anti-neutrophil cytoplasmic antibodies (ANCA)) IMMUNOLOGY or VIROLOGY Investigation £29
86256 Fluorescent noninfectious agent antibody; titer, each antibody IMMUNOLOGY or VIROLOGY Investigation £29
86277 Growth hormone, human (HGH), antibody IMMUNOLOGY or VIROLOGY Investigation £29
86341 Islet cell antibody, Anti-islet antibody IMMUNOLOGY or VIROLOGY Investigation £29
86352 Cellular function assay involving stimulation (eg, mitogen or antigen) and detection of biomarker (eg, ATP); (Formerly QuintilesIMS code TM012) IMMUNOLOGY or VIROLOGY Investigation £48
86403 Particle agglutination; screen, each antibody IMMUNOLOGY or VIROLOGY Investigation £29
86406 Particle agglutination; titer, each antibody IMMUNOLOGY or VIROLOGY Investigation £29
86590 Streptokinase, antibody IMMUNOLOGY or VIROLOGY Investigation £29
86602 Antibody; actinomyces IMMUNOLOGY or VIROLOGY Investigation £29
86603 Antibody; adenovirus IMMUNOLOGY or VIROLOGY Investigation £54
86606 Antibody; aspergillus IMMUNOLOGY or VIROLOGY Investigation £38
86611 Antibody; bartonella IMMUNOLOGY or VIROLOGY Investigation £60
86615 Antibody; bordetella IMMUNOLOGY or VIROLOGY Investigation £29
86618 Antibody; borrelia burgdorferi (lyme disease) IMMUNOLOGY or VIROLOGY Investigation £29
86619 Antibody; borrelia (relapsing fever) IMMUNOLOGY or VIROLOGY Investigation £29
86625 Antibody; Campylobacter IMMUNOLOGY or VIROLOGY Investigation £42
86628 Antibody; candida IMMUNOLOGY or VIROLOGY Investigation £29
86635 Antibody; coccidioides (coccidiodal) IMMUNOLOGY or VIROLOGY Investigation £55
86638 Antibody; coxiella brunetii (Q fever) IMMUNOLOGY or VIROLOGY Investigation £29
86641 Antibody; cryptococcus (cryptococcal) IMMUNOLOGY or VIROLOGY Investigation £29
86648 Antibody; diphtheria IMMUNOLOGY or VIROLOGY Investigation £29
86651 Antibody; encephalitis IMMUNOLOGY or VIROLOGY Investigation £29
86658 Antibody; enterovirus (eg, coxsackie, echo, polio) IMMUNOLOGY or VIROLOGY Investigation £29
86663 Antibody; Epstein-Barr virus (EB) (EBV) IMMUNOLOGY or VIROLOGY Investigation £29
86664 Antibody; Epstein-Barr (EB) virus, nuclear antigen (EBNA) IMMUNOLOGY or VIROLOGY Investigation £29
86665 Antibody; Epstein-Barr (EB) virus, viral capsid (VCA) IMMUNOLOGY or VIROLOGY Investigation £29
86671 Antibody; fungus, not elsewhere specified IMMUNOLOGY or VIROLOGY Investigation £29
86677 Antibody; helicobacter pylori (h Pylori level) (h Pylori IgG antibody) IMMUNOLOGY or VIROLOGY Investigation £29
86684 Antibody; hemophilus, haemophilus influenza IMMUNOLOGY or VIROLOGY Investigation £29
86687 Antibody; HTLV-I (HTLV I) IMMUNOLOGY or VIROLOGY Investigation £29
86688 Antibody; HTLV-II (HTLV II) IMMUNOLOGY or VIROLOGY Investigation £29
86689 Antibody; HTLV or HIV, confirmatory test (Western Blot) IMMUNOLOGY or VIROLOGY Investigation £13
86692 Antibody; hepatitis, delta agent, hepatitis D IMMUNOLOGY or VIROLOGY Investigation £70
86694 Antibody; herpes simplex (HSV serology) IMMUNOLOGY or VIROLOGY Investigation £29
86701 Antibody; HIV-1; HIV antibody detection; HTLV-III, elisa (Formerly code 86690) IMMUNOLOGY or VIROLOGY Investigation £13
86702 Antibody; HIV-2 IMMUNOLOGY or VIROLOGY Investigation £13
86703 Antibody; HIV-1 and HIV-2, single assay IMMUNOLOGY or VIROLOGY Investigation £13
86704 Hepatitis B core antibody (HBcAb); total IMMUNOLOGY or VIROLOGY Investigation £12
86705 Hepatitis B core antibody (HBcAb); IgM antibody IMMUNOLOGY or VIROLOGY Investigation £21
86706 Hepatitis B surface antibody (HBsAb) IMMUNOLOGY or VIROLOGY Investigation £12
86707 Hepatitis Be antibody (HBeAb) (HBeAg) IMMUNOLOGY or VIROLOGY Investigation £18
86708 Hepatitis A antibody (HAAb) (anti-HAV); total IMMUNOLOGY or VIROLOGY Investigation £13
86709 Hepatitis A antibody (HAAb) (anti-HAV); IgM antibody IMMUNOLOGY or VIROLOGY Investigation £13
86710 Antibody; influenza virus IMMUNOLOGY or VIROLOGY Investigation £29
86713 Antibody; legionella IMMUNOLOGY or VIROLOGY Investigation £29
86735 Antibody; mumps IMMUNOLOGY or VIROLOGY Investigation £29
86738 Antibody; mycoplasma IMMUNOLOGY or VIROLOGY Investigation £29
86741 Antibody; neisseria meningitidis (meningococcal conjugate C) IMMUNOLOGY or VIROLOGY Investigation £39
86747 Antibody; parvovirus IMMUNOLOGY or VIROLOGY Investigation £29
86750 Antibody; plasmodium (malaria) IMMUNOLOGY or VIROLOGY Investigation £29
86756 Antibody; respiratory syncytial virus (RSV anitbody) (RSV titer) IMMUNOLOGY or VIROLOGY Investigation £29
86757 Antibody; rickettsia IMMUNOLOGY or VIROLOGY Investigation £41
86759 Antibody; rotavirus IMMUNOLOGY or VIROLOGY Investigation £29
86762 Antibody; rubella IMMUNOLOGY or VIROLOGY Investigation £12
86765 Antibody; rubeola (measles) IMMUNOLOGY or VIROLOGY Investigation £29
86774 Antibody; tetanus (PRP-T antibody) IMMUNOLOGY or VIROLOGY Investigation £29
86777 Antibody; toxoplasma (toxoplasmosis Ab) IMMUNOLOGY or VIROLOGY Investigation £24
86778 Antibody; toxoplasma, IgM (toxoplasmosis Ab) IMMUNOLOGY or VIROLOGY Investigation £12
86780 Antibody; treponema pallidum IMMUNOLOGY or VIROLOGY Investigation £29
86787 Antibody; varicella zoster virus (VZV) IMMUNOLOGY or VIROLOGY Investigation £29
86790 Antibody; virus, viral not elsewhere specified IMMUNOLOGY or VIROLOGY Investigation £29
86793 Antibody; Yersinia IMMUNOLOGY or VIROLOGY Investigation £47
86800 Antibody; thyroglobulin IMMUNOLOGY or VIROLOGY Investigation £29
86803 Hepatitis C antibody (HCVab) (anti-HCV) IMMUNOLOGY or VIROLOGY Investigation £29
86804 Hepatitis C antibody; confirmatory test (eg, immunoblot) IMMUNOLOGY or VIROLOGY Investigation £29
86807 Serum screening for cytotoxic percent reactive antibody (PRA); standard method IMMUNOLOGY or VIROLOGY Investigation £29
86850 Antibody screen, RBC, antibody to specific drug, each serum technique IMMUNOLOGY or VIROLOGY Investigation £29
86970 Pretreatment of RBCs for use in RBC antibody detection, identification and/or compatibility testing; incubation with chemical agents or drugs each IMMUNOLOGY or VIROLOGY Investigation £48
87267 Infectious agent antigen detection by immunofluorescent technique; enterovirus, direct fluorescent antibody (formerly code 87199) IMMUNOLOGY or VIROLOGY Investigation £48
87271 Infectious agent antigen detection by immunofluorescent technique; cytomegalovirus, direct fluorescent antibody (formerly code 87198) IMMUNOLOGY or VIROLOGY Investigation £48
87277 Legionella IMMUNOLOGY or VIROLOGY Investigation £48
87280 Infectious agent antigen detection by immunofluorescent technique; respiratory syncytial virus IMMUNOLOGY or VIROLOGY Investigation £48
87305 Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; Aspergillus IMMUNOLOGY or VIROLOGY Investigation £48
87324 Infectious agent antigen detection by enzyme immunoassay technique qualitative or semiquantitative, multiple step method; Clostridium difficile toxin(s) IMMUNOLOGY or VIROLOGY Investigation £13
87328 Cryptosporidium/giardia IMMUNOLOGY or VIROLOGY Investigation £48
87335 Escherichia coli 0157 (E coli) IMMUNOLOGY or VIROLOGY Investigation £48
87338 Infectious agent antigen detection by enzyme immunoassay technique qualitative or semiquantitative, multiple step method; Helicobacter pylori, stool IMMUNOLOGY or VIROLOGY Investigation £48
87340 hepatitis B surface antigen (HBsAg) IMMUNOLOGY or VIROLOGY Investigation £12
87350 hepatitis Be antigen (HBeAg) IMMUNOLOGY or VIROLOGY Investigation £18
87380 Infectious agent antigen detection by enzyme immunoassay technique qualitative or semiquantitative, multiple step method; hepatitis, delta agent IMMUNOLOGY or VIROLOGY Investigation £12
87385 Histoplasma capsulatum IMMUNOLOGY or VIROLOGY Investigation £48
87390 HIV-1 IMMUNOLOGY or VIROLOGY Investigation £13
87391 HIV-2 IMMUNOLOGY or VIROLOGY Investigation £13
87400 Infectious agent antigen detection by enzyme immunoassay technique qualitative or semiquantitative, multiple step method; Influenza, A or B, each IMMUNOLOGY or VIROLOGY Investigation £48
87427 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) IMMUNOLOGY or VIROLOGY Investigation £48
87449 Infectious agent antigen detection by enzyme immunoassay technique qualitative or semiquantitative; multiple step method, not otherwise specified, each organism IMMUNOLOGY or VIROLOGY Investigation £48
87490 Chlamydia trachomatis, direct probe technique IMMUNOLOGY or VIROLOGY Investigation £12
87804 Influenza IMMUNOLOGY or VIROLOGY Investigation £48
87806 HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies IMMUNOLOGY or VIROLOGY Investigation £13
87807 Respiratory syncytial virus IMMUNOLOGY or VIROLOGY Investigation £48
87808 Trichomonas vaginalis IMMUNOLOGY or VIROLOGY Investigation £48
87809 Adenovirus IMMUNOLOGY or VIROLOGY Investigation £48
87810 Chlamydia trachomatis IMMUNOLOGY or VIROLOGY Investigation £12
87850 Neisseria gonorrhoeae IMMUNOLOGY or VIROLOGY Investigation £48
87880 Streptococcus, group A IMMUNOLOGY or VIROLOGY Investigation £48
87899 Infectious agent detection by immunoassay with direct optical observation; not otherwise specified IMMUNOLOGY or VIROLOGY Investigation £48
88348 Electron microscopy; diagnostic: For interpretation and report please use code R8348 IMMUNOLOGY or VIROLOGY Investigation £48
89060 Crystal identification by light microscopy with or without polarizing lens analysis, tissue or any body fluid (except urine) IMMUNOLOGY or VIROLOGY Investigation £48
91065 Breath hydrogen test, lactose tolerance test (eg, for detection of lactase deficiency, fructose intolerance, bacterial overgrowth or orocecal gastrointestinal transit) IMMUNOLOGY or VIROLOGY Investigation £48
T0801 Molecular Diagnostics: FLT3 / NPMI Mutation detection IMMUNOLOGY or VIROLOGY Investigation £48
T1014 Hemochromatosis Mutation Detection (CY282Y, H63D, S65C), Hereditary , by Polymerase Chain Reaction/Fluorescene Monitoring IMMUNOLOGY or VIROLOGY Investigation £48
T1205 NRAS Mutation detection by Pyrosequencing, N-RAS oncogene, Neuroblastoma RAS Viral Oncogene Homolog IMMUNOLOGY or VIROLOGY Investigation £48
T6711 Hepatitis A antibody (anti-HAV); IgG antibody (Formerly QuintilesIMS code 86711) IMMUNOLOGY or VIROLOGY Investigation £13
10022 Fine needle aspiration; with imaging guidance; include code 76942 or 77012 for imaging INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £673
11100 Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £527
11101 Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure); each separate/additional lesion (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £527
11755 Biopsy of nail unit (eg, plate, bed, matrix hyponychium, proximal and lateral nail folds) (separate procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £527
17311 Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation; first stage, up to 5 tissue blocks INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,494
17312 Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stains, head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; each additional stage after the first stage, up to 5 tissue blocks INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,494
17313 Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), of the trunk, arms, or legs; first stage, up to 5 tissue blocks. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,494
17314 Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stains, of the trunk, arms, or legs; each additional stage after the first stage, up to 5 tissue blocks INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,494
17315 Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stains; each additional block after the first 5 tissue blocks, any stage INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,494
19081 Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
19082 Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including stereotactic guidance (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
19083 Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,694
19084 Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including ultrasound guidance (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,694
19085 Biopsy, breast, with placement of breast localization device(s) (eg., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,046
19086 Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including magentic resonance guidance (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,046
19100 Biopsy of breast; percutaneous needle core: Includes anesthesia, Excludes preoperative and postoperative care; without imaging guidance INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
19101 Biopsy of breast; open, incisional: Includes anesthesia, Excludes preoperative and postoperative care. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
20200 Biopsy of muscle; superficial INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,000
20205 Biopsy of muscle; deep INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,625
20206 Biopsy of muscle; percutaneous needle INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £682
20220 Biopsy of bone; by trocar or needle: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care; superficial(eg, ilium, sternum, spinous process, ribs) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,002
20225 Biopsy of bone; trocar or needle, deep (eg, vertebral body, femur) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,002
20245 Biopsy, bone, open; deep (eg. Humerus, ischium, femur) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,002
21550 Biopsy of soft tissue of neck or thorax INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £527
27330 Arthrotomy, knee; with synovial biopsy only INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
27331 Arthrotomy, knee; including joint exploration, biopsy or removal of loose or foreign bodies INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
29900 Arthroscopy, metacarpophalangeal joint, diagnostic, includes synovial biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
30100 Biopsy, intranasal: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
31231 Nasal, sinus endoscopy, rhinoscopy; diagnostic; unilateral or bilateral INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £658
31237 Nasal, sinus endoscopy, rhinoscopy; surgical, with biopsy, polypectomy or debridement (separate procedures) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £801
31510 Laryngoscopy, indirect; with biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £615
31576 Laryngoscopy, flexible fiberoptic; with biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
31625 Bronchoscopy, rigid or flexible, with or without flouroscopic guidance, with bronchial or endobronchial biopsy(s), single or multiple sites; diagnostic, with or without cell washing (separate procedure); with anesthesia and typical post-operative care; use in conjunction with code 31620 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,660
31628 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,660
31652 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with endobronchial ultrasound (EBUS) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]), one or two mediastinal and/or hilar lymph node stations or structures INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,313
31653 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with endobronchial ultrasound (EBUS) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]), 3 or more mediastinal and/or hilar lymph node stations or structures INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,313
32096 Thoracotomy, with diagnostic biopsy(ies) of lung infiltrate(s) (eg, wedge, incisional), unilateral INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32097 Thoracotomy, with diagnostic biopsy(ies) of lung nodule(s) or mass(es) (eg, wedge, incisional), unilateral INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32098 Thoracotomy, with biopsy(ies) of pleura INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32405 Biopsy of lung or mediastinum; percutaneous needle: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32555 Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance (formerly Code 32421) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,643
32557 Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance, (formerly Code 32421) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,584
32604 Thoracoscopy, diagnostic (separate procedure); pericardial sac, with biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32606 Thoracoscopy, diagnostic (separate procedure); mediastinal space, with biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32607 Thoracoscopy, with diagnostic biopsy(ies) of lung infiltrates(s) (eg, wedge, incisional), unilateral (formerly code 32602) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32608 Thoracoscopy, with diagnostic biopsy(ies) of lung module(s) or mass(es) (eg, wedges, incisional), unilateral (formerly code 32602) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
32609 Thoracoscopy, with biopsy(ies) of pleura (formerly code 32602) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
36251 Selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral (formerly code 75722) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,860
36252 Selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image post processing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral (formerly code 75722, 75724) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,860
36253 Superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image pos tprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral (formerly code 75722, 75724) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,860
36254 Superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image post processing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral (formerly code 75722, 75724) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,860
37200 Transcatheter biopsy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
37228 Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty; moderate sedation; please include code 37250 if needed INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37229 Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with atherectomy, includes angioplasty within the same vessel, when performed; moderate sedation; please include code 37250 if needed INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37230 Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed; moderate sedation; please include code 37250 if needed INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37231 Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed; moderate sedation; please include code 37250 if needed INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37233 Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with atherectomy, includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure); moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37234 Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure); moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37235 Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty with the same vessel, when performed (list separately in addition to code for primary procedure); moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37236 Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial artery (Suggested replacement code for 37205) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37237 Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; each additional artery (list separately in addition to code for primary) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37238 Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein (Suggested replacement code for 37205) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37239 Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; each additional vein (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £6,209
37252 Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; initial noncoronary vessel (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £563
37253 Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; each additional noncoronary vessel (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £563
43239 Upper gastrointestinal endoscopy including esophagus, oesophagus, stomach, and either the duodenum and/or jejunum as appropriate; with biopsy; single or multiple; moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,273
43242 Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s) (includes endoscopic ultrasound examination of the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,236
43246 Upper gastrointestinal endoscopy including esophagus, stomach, and either the duodenum and/or jejunum as appropriate; with directed placement of percutaneous gastrostomy tube; moderate sedation INTERVENTIONAL DIAGNOSTICS Investigation £187
43254 Esophagogastroduodenoscopy, flexible, transoral; with endoscopic mucosal INTERVENTIONAL DIAGNOSTICS Investigation £187
43605 Biopsy of stomach, gastric biopsy; by laparotomy INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
43754 Gastric intubation and aspiration, diagnostic; single specimen (eg, acid analysis) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £673
43755 Gastric intubation and aspiration diagnostic; collection of multiple fractional specimens with gastric stimulation, single or double lumen tube (gastric secretory study) (eg, histamine, insulin, pentagastrin, calcium, secretin), includes drug administration INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £673
43756 Duodenal intubation and aspiration, diagnostic, includes image guidance; single specimen (eg. Bile study for crystals or afferent loop culture) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £673
43757 Duodenal intubation and aspiration, diagnostic, includes image guidance; collection of multiple fractional specimens with pancreatic or gallbladder stimulation, single or double lumen tube, includes drug administration INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £673
43775 Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (ie, sleeve gastrectomy) INTERVENTIONAL DIAGNOSTICS Investigation £1,601
44020 Enterotomy, small intestine, other than duodenum; for exploration, biopsy(s) or foreign body removal INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
44100 Biopsy of intestine, colon; by capsule, tube or peroral: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
44180 Laparoscopy, surgical, enterolysis INTERVENTIONAL DIAGNOSTICS Investigation £187
44385 Endoscopic evaluation of small intestinal (abdominal or pelvic) pouch (endoscopy); diagnostic; with or without collection of specimen by brushing or washing; moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,129
44386 Endoscopic evaluation of small intestinal (abdominal or pelvic) pouch (endoscopy); with biopsy; single or multiple; moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,273
44389 Colonoscopy through stoma (endoscopy); with biopsy; single or multiple; moderate sedation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,273
45305 Proctosigmoidoscopy, rigid; with biopsy, single or multiple INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
45330 Sigmoidoscopy, flexible; diagnostic, with or without collection of specimen(s) by brushing or washing INTERVENTIONAL DIAGNOSTICS Investigation £187
45331 Sigmoidoscopy, flexible; diagnostic, with biopsy; single or multiple INTERVENTIONAL DIAGNOSTICS Investigation £144
45333 Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps INTERVENTIONAL DIAGNOSTICS Investigation £144
45338 Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique INTERVENTIONAL DIAGNOSTICS Investigation £1,129
45346 Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed) INTERVENTIONAL DIAGNOSTICS Investigation £1,601
45380 Colonoscopy, flexible; with biopsy, single or multiple INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
45388 Colonoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed); moderate sedation INTERVENTIONAL DIAGNOSTICS Investigation £1,601
45390 Colonoscopy, flexible; with endoscopic mucosal resection INTERVENTIONAL DIAGNOSTICS Investigation £187
46600 Anoscopy; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure) INTERVENTIONAL DIAGNOSTICS Investigation £1,129
46604 Anoscopy; with dilation (eg, balloon, guide wire, bougie) INTERVENTIONAL DIAGNOSTICS Investigation £187
46606 Anoscopy; with biopsy, single or multiple INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
47562 Laparoscopy, cholecystectomy, excision of gallbladder; surgical INTERVENTIONAL DIAGNOSTICS Investigation £187
47563 Laparoscopy, surgical; cholecystectomy with cholangiography INTERVENTIONAL DIAGNOSTICS Investigation £187
47564 Laparoscopy, surgical; cholecystectomy with exploration of common duct INTERVENTIONAL DIAGNOSTICS Investigation £187
47570 Laparoscopy, surgical; cholecystoenterostomy INTERVENTIONAL DIAGNOSTICS Investigation £187
49320 Laparoscopy, abdomen, peritoneum, and omentum diagnostic with or without collection of specimen(s) by brushing or washing (separate procedure) INTERVENTIONAL DIAGNOSTICS Investigation £1,129
49418 Insertion of tunneled intraperitoneal catheter (eg, dialysis, intraperitoneal chemotherapy instillation, management of ascites), complete procedure, including imaging guidance, catheter placement, contrast injection when performed, and radiological supervision and interpretation, percutaneous INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £881
51798 Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £563
51992 Laparoscopy, surgical; sling operation for stress incontine (eg, fascia or synthetic) INTERVENTIONAL DIAGNOSTICS Investigation £1,129
52000 Cystourethroscopy (separate procedure) INTERVENTIONAL DIAGNOSTICS Investigation £187
52005 Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; INTERVENTIONAL DIAGNOSTICS Investigation £1,129
52224 Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) or treatment of lesions INTERVENTIONAL DIAGNOSTICS Investigation £1,129
52332 Cystourethroscopy, with insertion of indwelling ureteral stent (e Gibbons or double-J type) INTERVENTIONAL DIAGNOSTICS Investigation £658
52351 Cystourethroscopy, with ureteroscopy and/or pyeloscopy; diagnostic INTERVENTIONAL DIAGNOSTICS Investigation £187
52353 Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lith (ureteral catheterization is included) INTERVENTIONAL DIAGNOSTICS Investigation £1,129
57452 Colposcopy (vaginoscopy) INTERVENTIONAL DIAGNOSTICS Investigation £187
57460 Colposcopy (vaginoscopy); with loop electrode excision procedure of the cervix INTERVENTIONAL DIAGNOSTICS Investigation £1,129
58555 Hysteroscopy; diagnostic INTERVENTIONAL DIAGNOSTICS Investigation £187
58670 Laparoscopy; surgical, with fulguration of oviducts INTERVENTIONAL DIAGNOSTICS Investigation £187
61140 Burr hole(s) or trephine; with biopsy of brain or intracranial lesion INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,558
61750 Stereotactic biopsy, aspiration, or excision, including burr hole(s) for intracranial lesion; INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £202
61751 Stereotactic biopsy, aspiration, or excision, including burr hole(s) for intracranial lesion; with computerized axial tomography and/or magnetic resonance guidance INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £202
67028 Intravitreal injection of a pharmacologic agent: includes ophthalmoscopy or ultrasound for needle location, post treatment observation and post injection tonometry; unilateral; for sterile room please add code NP009 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,007
75989 Radiological guidance for percutaneous drainage of abscess or specimen collection (ie, fluoroscopy, ultrasound, or computed axial tomography) with possible placement of indwelling catheter: Includes radiological supervision and interpretation INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £359
76000 Fluoroscopy; up to one hour physician time (eg, cardiac fluoroscopy) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £345
77001 Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or catheter with related venography radiologic supervision and interpretation, and radiographic documentation of final catheter position): Reporting code R7001 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,133
77002 Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device): Reporting code R7002. INTERVENTIONAL DIAGNOSTICS Investigation £191
77011 Computed tomography guidance for stereotactic localization: Reporting code R7011 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £169
77012 Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation: Reporting code R7012. INTERVENTIONAL DIAGNOSTICS Investigation £405
77013 Computed tomography guidance for, and monitoring of, parenchymal tissue ablation: Reporting code R7013 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £169
77014 Computed tomography guidance for placement of radiation therapy fields: Reporting code R7014 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £169
77021 Magnetic resonance guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation: Reporting code R7021 INTERVENTIONAL DIAGNOSTICS Investigation £404
77022 Magnetic resonance guidance for, and monitoring of, parenchymal tissue ablation: Reporting code R7022 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £404
78647 Cerebrospinal fluid flow, imaging (not including introduction of material) (CSF), tomographic (SPECT): Reporting code R8647. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £733
88172 Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site INTERVENTIONAL DIAGNOSTICS Investigation £136
88173 Cytopathology, evaluation of fine needle aspirate; interpretation and report INTERVENTIONAL DIAGNOSTICS Investigation £136
94806 Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement): Reporting code R4806 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,067
95800 Sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time: Reporting code R5800 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,067
95801 Sleep study, unattended, simultaneous recording; minimum of heart rate, oxygen saturation, and respiratory analysis (eg, by airflow or peripheral arterial tone): Reporting code R5801 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £2,067
0346T Ultrasound, elastography (List separately in addition to code for primary procedure) INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £138
GSCON Gastric and colonic motility scintigraphy study including radiopharmaceutical ingestion followed by images between 0 to 24 hours; HIDA-CCK cholescintigraphy; selenium-75 homotaurocholate (SEHCAT); Reporting code RSCON. INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £4,330
T0601 Biopsy of Bone with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,002
T0602 Biopsy of Liver with ancillary costs including biopsy handling, ultrasonic guidance, supplies, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0603 Biopsy, intranasal with ancillary costs including biopsy handling, supplies, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0604 Bronchoscopy with biopsy with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,728
T0605 Biopsy of Lung or Mediastinum; percutaneous needle; with ancillary cost including biopsy handling, supplies, ultrasonic guidance, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,154
T0606 Bone marrow biopsy by trocar needle with ancillary costs including biopsy handling, supplies, coordinator and physician fee, daily facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,002
T0607 Upper gastrointestinal endoscopy with biopsy with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,273
T0608 Biopsy of stomach, gastric biopsy by capsule, tube or peroral, with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0609 Biopsy of stomach by laparotomy with ancillary costs including biopsy handling, supplies, ultrasonic guidance, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0610 Colonoscopy with specimen collection with ancillary costs including biopsy handling, supplies, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0611 Renal biopsy by trocar needle with ancillary costs including biopsy handling, supplies, ultrasonic guidance, coordinator and physician fee, overnight facility fee INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0612 Renal biopsy by surgical exposure, with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0613 Thyroid biopsy with ancillary costs including biopsy handling, supplies, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0614 Nerve Biopsy with ancillary costs including biopsy handling, supplies, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0615 Endomyocardial biopsy, myocardial biopsy with ancillary costs including biopsy handling, supplies, ultrasonic guidance, coordinator and physician fee, overnight facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,154
T0616 Biopsy of Prostate with ancillary costs, transrectal, including biopsy handling, supplies, ultrasonic needle guidance, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T0617 Biopsy of Lymph node, superficial including biopsy handling, supplies, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,666
T0618 Breast Biopsy percutaneous needle, with ancillary costs including biopsy handling, supplies, ultrasonic needle guidance, coordinator and physician fee, day facility INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,085
T1402 Transjugular liver biopsy including ancillary costs such as facility fee, supplies, biopsy handling, staff time, anesthesia. This complete code also includes CPT codes 37200,36011 (Selective catheter placement), 75970 (radiological supervision ,without interpretation: Reporting code R5970), 76937 (Ultrasound guidance, without interpretation: Reporting code R6937) If Hepatic venography is required please include code 75889 INTERVENTIONAL DIAGNOSTICS Intervention includes Investigation (where applicable) £1,149
80150 Amikacin MICROBIOLOGY Investigation £49
80156 Carbamazepine; total MICROBIOLOGY Investigation £35
80158 Cyclosporine (CyA) (CsA) MICROBIOLOGY Investigation £35
80162 Digoxin MICROBIOLOGY Investigation £35
80164 Dipropylacetic acid (valproic acid) MICROBIOLOGY Investigation £35
80168 Ethosuximide MICROBIOLOGY Investigation £47
80170 Gentamicin MICROBIOLOGY Investigation £35
80173 Haloperidol MICROBIOLOGY Investigation £35
80176 Lidocaine MICROBIOLOGY Investigation £35
80178 Lithium MICROBIOLOGY Investigation £35
80184 Phenobarbital MICROBIOLOGY Investigation £35
80185 Phenytoin; total MICROBIOLOGY Investigation £35
80186 Phenytoin; total; free MICROBIOLOGY Investigation £35
80188 Primidone MICROBIOLOGY Investigation £35
80190 Procainamide MICROBIOLOGY Investigation £35
80194 Quinidine MICROBIOLOGY Investigation £35
80197 Tacrolimus; whole blood by IMx analysis MICROBIOLOGY Investigation £35
80198 Theophylline MICROBIOLOGY Investigation £35
80200 Tobramycin MICROBIOLOGY Investigation £35
80201 Topiramate MICROBIOLOGY Investigation £35
80202 Vancomycin MICROBIOLOGY Investigation £35
80299 Quantitation of drug, not elsewhere specified MICROBIOLOGY Investigation £35
80305 Drug test(s), presumptive, any number of drug classes, direct optical observation only includes sample validation when performed MICROBIOLOGY Investigation £35
80306 Drug test(s), presumptive, any number of drug classes, instrument assisted direct optical observation, includes sample validation when performed MICROBIOLOGY Investigation £35
80307 Drug test(s), presumptive, instrument chemistry analyzers chromatography, and mass spectrometry includes sample validation when performed, per date of service MICROBIOLOGY Investigation £35
80320 Alcohols MICROBIOLOGY Investigation £35
80321 Alcohol biomarkers; 1 or 2 MICROBIOLOGY Investigation £35
80322 Alcohol biomarkers; 3 or more MICROBIOLOGY Investigation £35
80323 Alkaloids, not otherwise specified MICROBIOLOGY Investigation £35
80324 Amphetamines; 1 or 2 MICROBIOLOGY Investigation £35
80325 Amphetamines; 3 or 4 MICROBIOLOGY Investigation £35
80326 Amphetamines; 5 or more MICROBIOLOGY Investigation £35
80327 Anabolic steroids; 1 or 2 MICROBIOLOGY Investigation £35
80328 Anabolic steroids; 3 or more MICROBIOLOGY Investigation £35
80329 Analgesics, non-opioid; 1 or 2 MICROBIOLOGY Investigation £35
80330 Analgesics, non-opioid; 3-5 MICROBIOLOGY Investigation £35
80331 Analgesics, non-opioid; 6 or more MICROBIOLOGY Investigation £35
80335 Antidepressants, tricyclic and other cyclicals; 1 or 2 MICROBIOLOGY Investigation £35
80336 Antidepressants, tricyclic and other cyclicals; 3-5 MICROBIOLOGY Investigation £35
80337 Antidepressants, tricyclic and other cyclicals; 6 or more MICROBIOLOGY Investigation £35
80339 Antiepileptics, not otherwise specified; 1-3 MICROBIOLOGY Investigation £35
80340 Antiepileptics, not otherwise specified; 4-6 MICROBIOLOGY Investigation £35
80341 Antiepileptics, not otherwise specified; 7 or more MICROBIOLOGY Investigation £35
80342 Antipsychotics, not otherwise specified; 1-3 MICROBIOLOGY Investigation £35
80343 Antipsychotics, not otherwise specified; 4-6 MICROBIOLOGY Investigation £35
80344 Antipsychotics, not otherwise specified; 7 or more MICROBIOLOGY Investigation £35
80345 Barbiturates MICROBIOLOGY Investigation £35
80346 Benzodiazepines; 0-12 MICROBIOLOGY Investigation £35
80347 Benzodiazepines; 13 or more MICROBIOLOGY Investigation £35
80353 Cocaine MICROBIOLOGY Investigation £35
80358 Methadone MICROBIOLOGY Investigation £35
80361 Opiates, 1 or more MICROBIOLOGY Investigation £35
80362 Opioids and opiate analogs; 1 or 2 MICROBIOLOGY Investigation £35
80363 Opioids and opiate analogs; 3 or 4 MICROBIOLOGY Investigation £35
80364 Opiods and opiate analogs; 5 or more MICROBIOLOGY Investigation £35
80368 Sedative hypnotics (non-benzodiazepines) MICROBIOLOGY Investigation £35
80369 Skeletal muscle relaxants; 1 or 2 MICROBIOLOGY Investigation £35
80370 Skeletal muscle relaxants; 3 or more MICROBIOLOGY Investigation £35
86060 Antistreptolysin 0 (ASO) (ASLO); titer MICROBIOLOGY Investigation £13
86480 Tuberculosis test, cell mediated immunity measurement of gamma interferon antigen response (e.g. QFTB: QuantiFeron-TB Gold test) MICROBIOLOGY Investigation £42
86481 Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension MICROBIOLOGY Investigation £18
86580 Skin test, tuberculosis (TB); intradermal, Mantoux screening test, Tuberculin Sensitivity Test, Pirquet test, PPD test for Purified Protein Derivative MICROBIOLOGY Investigation £18
87040 Culture, bacterial; blood, serum, with isolation and presumptive identification of isolates MICROBIOLOGY Investigation £18
87045 Culture, bacterial; feces, fecal, stool, with isolation and presumptive identification of isolates MICROBIOLOGY Investigation £18
87046 Culture, bacterial; stool, aerobic, additional pathogens, isolation and presumptive identification of isolates, each plate MICROBIOLOGY Investigation £18
87070 Culture, bacterial; any other source except urine, blood, serum, stool or feces, with isolation and presumptive identification of isolates MICROBIOLOGY Investigation £12
87071 Culture, bacterial; quantitative, aerobic with isolation an identification of isolates, any source except urine, blood or stool MICROBIOLOGY Investigation £12
87075 Culture, bacterial; any anaerobic source, except blood, presumptive identification of isolates MICROBIOLOGY Investigation £18
87076 Culture, bacterial; anaerobic isolate, additional methods required for definitive identification, each isolatev MICROBIOLOGY Investigation £18
87077 Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate MICROBIOLOGY Investigation £18
87081 Culture, pathogenic organisms, presumptive, screening only; including nasal swab MICROBIOLOGY Investigation £18
87086 Culture, bacterial; urine, quantitative colony count MICROBIOLOGY Investigation £12
87088 Culture, bacterial; urine, with isolation and presumptive identification of isolates MICROBIOLOGY Investigation £12
87101 Culture, fungi, fungal (mold or yeast) isolation; skin, hair or nail, with presumptive identification of isolates MICROBIOLOGY Investigation £18
87102 Culture, fungi, fungal (mold or yeast) isolation; other source (except blood), with presumptive identification of isolates MICROBIOLOGY Investigation £18
87103 Culture, fungi, fungal (mold or yeast) isolation; blood, serum, with presumptive identification of isolates MICROBIOLOGY Investigation £18
87106 Culture, fungi, fungal (mold or yeast); definitive identification MICROBIOLOGY Investigation £18
87109 Culture, mycoplasma; any source MICROBIOLOGY Investigation £18
87110 Culture, chlamydia; any source MICROBIOLOGY Investigation £33
87116 Culture, tubercle or other acid-fast bacilli (eg, TB, AFB); any source MICROBIOLOGY Investigation £18
87140 Culture, typing; immunofluorescent method, each antiserum MICROBIOLOGY Investigation £18
87143 Culture, typing; gas liquid chromatography (GLC) or high pressure liquid chromatography (HPLC) method MICROBIOLOGY Investigation £18
87147 Culture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserum MICROBIOLOGY Investigation £18
87230 Toxin or antitoxin assay, tissue culture (eg, Clostridium difficile toxin (C-diff)) MICROBIOLOGY Investigation £13
88230 Tissue culture for non-neoplastic disorders; lymphocyte MICROBIOLOGY Investigation £18
88237 Tissue culture for neoplastic disorders; bone marrow, blood cells MICROBIOLOGY Investigation £18
88239 Tissue culture for neoplastic disorders; solid tumor MICROBIOLOGY Investigation £18
89220 Sputum, obtaining specimen, aerosol induced technique (formerly code 89350) MICROBIOLOGY Investigation £18
94640 Nonpressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes (e.g. aerosol generator, nebulizer) MICROBIOLOGY Investigation £18
T0703 Viral Serology: Hepatitis B, HBsAG, Hepatitis C,HCV, Human immunodeficiency virus, HIV MICROBIOLOGY Investigation £13
T0717 Cytogenetics Analysis including tissue culture; molecular cytogenetics with karyotyping and banding MICROBIOLOGY Investigation £18
T2964 Glucosaminoglycans (GAG), N-acetyl beta-glucosaminidase (NAG); urine (Formerly QuintilesIMS code 82964) MICROBIOLOGY Investigation £12
T6585 Skin test check, tuberculosis (TB); tine test check (Formerly QuintilesIMS code 86585) MICROBIOLOGY Investigation £18
T7072 Culture, bacterial; throat or nose, aerobic with definitive identification (Formerly QuintilesIMS code 87072) MICROBIOLOGY Investigation £18
76073 DEXA Per site NUCLEAR MEDICINE Investigation £88
78013 Thyroid imaging Complex NUCLEAR MEDICINE Investigation £537
78195 Lymphatics and lymph nodes imaging Any area NUCLEAR MEDICINE Investigation £1,092
78205 SPECT Any area NUCLEAR MEDICINE Investigation £354
78227 Hepatobiliary system imaging, including gallbladder when present; with pharmacologic intervention, including quantitative measurement(s) when performed. Reporting code R8227 Any area NUCLEAR MEDICINE Investigation £832
78231 Salivary gland imaging 1 or more sites NUCLEAR MEDICINE Investigation £515
78350 Bone Scan 1 Site NUCLEAR MEDICINE Investigation £213
78351 Bone Scan 5 sites/more/whole body NUCLEAR MEDICINE Investigation £317
78451 SPECT 5 sites/more/whole body NUCLEAR MEDICINE Investigation £475
78452 SPECT any area NUCLEAR MEDICINE Investigation £354
78608 PET Scan (CT/MRI) Any area NUCLEAR MEDICINE Investigation £1,542
78803 SPECT any area NUCLEAR MEDICINE Investigation £354
78815 PET Scan (CT/MRI) Partial body NUCLEAR MEDICINE Investigation £1,542
92920 PET Scan (CT/MRI) Whole body NUCLEAR MEDICINE Investigation £1,595
92921 Percutaneous transluminal coronary angioplasty; each additional branch of a major coronary artery. (formerly codes 92980, 92981, 92984, 92995, 92996) NUCLEAR MEDICINE Investigation £4,794
NIHR_INV_053 Brain Imaging (Choline) for Tumour NUCLEAR MEDICINE Investigation £847
NIHR_INV_054 Brain Imaging (Thallium) for tumour NUCLEAR MEDICINE Investigation £332
NIHR_INV_056 DATScan Any area NUCLEAR MEDICINE Investigation £309
NIHR_INV_057 DMSA Renal NUCLEAR MEDICINE Investigation £483
NIHR_INV_059 EDTA Renal Clearance (GFR) Any area NUCLEAR MEDICINE Investigation £3,803
NIHR_INV_060 I131 Therapy Ca thyroid NUCLEAR MEDICINE Investigation £423
NIHR_INV_061 I131 Therapy Thyrotoxicosis IP NUCLEAR MEDICINE Investigation £1,029
NIHR_INV_062 I131 Therapy Thyrotoxicosis OP NUCLEAR MEDICINE Investigation £873
NIHR_INV_063 Intestinal absorption (75-Se) Any area NUCLEAR MEDICINE Investigation £370
NIHR_INV_064 Lacrimal Scan (Dacroscintigraphy) Any area NUCLEAR MEDICINE Investigation £625
NIHR_INV_065 Lymphatics and lymph nodes imaging Any area NUCLEAR MEDICINE Investigation £1,092
NIHR_INV_066 MAG3 Dynamic Renal Scan NUCLEAR MEDICINE Investigation £532
NIHR_INV_067 MAG3 Dynamic Renal Scan + Bladder Emptying NUCLEAR MEDICINE Investigation £1,506
NIHR_INV_068 MAG3 Dynamic Renal Scan With Captopril NUCLEAR MEDICINE Investigation £1,200
NIHR_INV_069 Meckels Scan Complex NUCLEAR MEDICINE Investigation £336
NIHR_INV_070 MIBG Imaging Any area NUCLEAR MEDICINE Investigation £2,095
T0718 DEXA Per site NUCLEAR MEDICINE Investigation £88
T6072 DEXA Per site NUCLEAR MEDICINE Investigation £88
92235 Ophthalmic imaging: Fluorescein angiography (per eye) OPTHALMOLOGY Investigation £133
92240 Ophthalmic imaging: Indocyanine-green (ICG) angiography OPTHALMOLOGY Investigation £166
92275 Ocular electrophysiology: Electroretinography (ERG) OPTHALMOLOGY Investigation £295
92285 Ophthalmic imaging: External ocular photography (eg, close-up photography, slit lamp photography, goniophotography, stereo-photography) OPTHALMOLOGY Investigation £44
92287 Ophthalmic imaging: Anterior segment fluorescein angiography or other specialised imaging OPTHALMOLOGY Investigation £166
92541 Ophthalmic examination: Spontaneous nystagmus test, including gaze and fixation nystagmus; with recording OPTHALMOLOGY Investigation £177
92542 Ophthalmic examination: Positional nystagmus test, minimum of 4 positions, with recording OPTHALMOLOGY Investigation £177
92545 Ophthalmic examination: Oscillating tracking test, with recording OPTHALMOLOGY Investigation £177
NIHR_INV_071 Ophthalmology clinics OPTHALMOLOGY Investigation £156
NIHR_INV_072 Medical / Ophthalmic history OPTHALMOLOGY Investigation £59
NIHR_INV_073 Visual Acuity Testing: Best-corrected distance visual acuity, either or both eyes (Add refraction if needed) OPTHALMOLOGY Investigation £59
NIHR_INV_074 Visual Acuity Testing: Contrast sensitivity, either or both eyes (Add refraction if needed) OPTHALMOLOGY Investigation £99
NIHR_INV_075 Visual Acuity Testing: Low luminance acuity, either or both eyes (Add refraction if needed) OPTHALMOLOGY Investigation £59
NIHR_INV_076 Ophthalmic examination: Posterior segment only (Indirect ophthalmoscopy) per eye OPTHALMOLOGY Investigation £44
NIHR_INV_077 Ophthalmic examination: Anterior and posterior segment examination OPTHALMOLOGY Investigation £93
NIHR_INV_078 Ophthalmic examination: Intra-ocular pressure (per eye) OPTHALMOLOGY Investigation £21
NIHR_INV_079 Ophthalmic imaging: Autofluorescence Imaging OPTHALMOLOGY Investigation £138
NIHR_INV_080 Ophthalmic imaging: Adaptive Optics Imaging OPTHALMOLOGY Investigation £104
NIHR_INV_081 Visual field testing: Micro-perimetry OPTHALMOLOGY Investigation £274
NIHR_INV_083 Ophthalmic imaging: Fundus photography of disc / macula, incl. stereo photography OPTHALMOLOGY Investigation £70
NIHR_INV_097 Visual Acuity Testing: Refraction for distance and near OPTHALMOLOGY
£50
NIHR_INV_099 Visual acuity testing: Near visual acuity and reading speed, either or both eyes (Add refraction if needed) OPTHALMOLOGY
£59
NIHR_INV_100 Visual field testing: Peripheral visual field testing (Goldmann visual fields) OPTHALMOLOGY
£100
NIHR_INV_101 Visual field testing: Preferential Hyperacuity Perimetry OPTHALMOLOGY
£149
NIHR_INV_102 Ophthalmic examination: Orthoptic assessment OPTHALMOLOGY
£85
NIHR_INV_103 Ophthalmic examination: Pachymetry OPTHALMOLOGY
£32
NIHR_INV_105 Ophthalmic imaging: OCT-angiography OPTHALMOLOGY
£128
NIHR_INV_106 Ophthalmic imaging: Ultra-widefield fundus photography (incl 7 field imaging) OPTHALMOLOGY
£128
NIHR_INV_107 Ophthalmic imaging: Ultra-widefeld fluorescein angiography OPTHALMOLOGY
£212
NIHR_INV_108 Ophthalmic imaging: Ultra-widefield autofluorescence Imaging OPTHALMOLOGY
£102
NIHR_INV_109 Ophthalmic imaging: Corneal topography OPTHALMOLOGY
£112
NIHR_INV_110 Ophthalmic imaging: Specular microscopy OPTHALMOLOGY
£92
NIHR_INV_111 Ocular electrophysiology: Electroretinography (ERG) and Visual evoked potential (VEP) OPTHALMOLOGY
£424
NIHR_INV_112 Intra-vitreal injection OPTHALMOLOGY
£100
T2282 Ophthalmic examination: Anterior segment only (Slit-lamp examination) Either or both eyes OPTHALMOLOGY Investigation £49
37609 Ligation or biopsy, temporal artery PATHOLOGY Investigation £144
38221 Bone marrow biopsy; by trocar or needle PATHOLOGY Investigation £58
38500 Biopsy or excision of lymph node(s); open: PATHOLOGY Investigation £723
38505 Biopsy or excision of lymph node(s); by needle, superficial (eg, cervical, inguinal, axillary) PATHOLOGY Investigation £723
38510 Biopsy or excision of lymph node(s); open, deep cervical node(s) PATHOLOGY Investigation £723
38525 Biopsy or excision of lymph node(s); open, deep axillary node(s) PATHOLOGY Investigation £723
38530 Biopsy or excision of lymph node(s); open, internal mammary node(s) PATHOLOGY Investigation £723
40490 Biopsy of lip PATHOLOGY Investigation £56
40808 Biopsy, vestibule of mouth: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care. PATHOLOGY Investigation £56
41100 Biopsy of tongue; anterior two-thirds PATHOLOGY Investigation £56
41108 Biopsy of floor of mouth PATHOLOGY Investigation £56
42400 Biopsy of salivary gland; needle PATHOLOGY Investigation £56
42405 Biopsy of salivary gland; incisional PATHOLOGY Investigation £56
45100 Rectal biopsy, biopsy of anorectal wall; anal approach PATHOLOGY Investigation £144
47000 Biopsy of liver; percutaneous needle: Includes anesthesia, Excludes preoperative and postoperative care. PATHOLOGY Investigation £144
47001 Biopsy of liver, needle; when done for indicated purpose at time of other major procedure (List separately in addition to code for primary procedure) PATHOLOGY Investigation £144
48102 Biopsy of pancreas; percutaneous needle PATHOLOGY Investigation £144
49180 Biopsy of abdomen, abdominal or retroperitoneal mass; percutaneous needle PATHOLOGY Investigation £144
49321 Laparoscopy; surgical, with biopsy; single or multiple PATHOLOGY Intervention includes Investigation (where applicable) £1,085
50200 Renal biopsy; by trocar or needle; moderate sedation PATHOLOGY Investigation £144
50205 Renal biopsy; by surgical exposure of kidney: Includes anesthesia, Excludes preoperative and postoperative care. PATHOLOGY Intervention includes Investigation (where applicable) £1,085
52204 Cystourethroscopy, cystoscopy; with biopsy of bladder PATHOLOGY Intervention includes Investigation (where applicable) £144
54500 Biopsy of testis, testicle; needle (separate procedure) PATHOLOGY Investigation £144
54505 Biopsy of testis, testical; incisional (separate procedure) PATHOLOGY Investigation £144
55700 Biopsy of prostate (TURP); by needle or punch: Includes preoperative care, anesthesia and typical postoperative care; single or multiple, any approach PATHOLOGY Intervention includes Investigation (where applicable) £1,085
55705 Biopsy of prostate; incisional PATHOLOGY Investigation £144
57100 Biopsy of vaginal mucosa; simple PATHOLOGY Investigation £144
57105 Biopsy of vaginal mucosa; extensive, requiring suture (including cysts) PATHOLOGY Investigation £144
57454 Colposcopy (vaginoscopy); with biopsy(s) of the cervix and/or endocervical curettage PATHOLOGY Intervention includes Investigation (where applicable) £1,085
57500 Biopsy, cervical, cervix uteri, single or multiple, or local excision of lesion: Includes anesthesia, Excludes preoperative and postoperative care; with or without fulguration PATHOLOGY Intervention includes Investigation (where applicable) £1,085
58100 Endometrial biopsy, uterine biopsy: Includes anesthesia, Excludes preoperative and postoperative care; without cervical dilation, any method PATHOLOGY Intervention includes Investigation (where applicable) £1,085
58558 Hysteroscopy; surgical, with biopsy of endometrium and/or polypectomy PATHOLOGY Intervention includes Investigation (where applicable) £1,085
60100 Biopsy of thyroid; percutaneous core needle: Includes anesthesia, Excludes preoperative and postoperative care. PATHOLOGY Intervention includes Investigation (where applicable) £1,085
64795 Biopsy of nerve: Includes preoperative care (including a medical history and physical examination), anesthesia and typical postoperative care. PATHOLOGY Intervention includes Investigation (where applicable) £1,085
67346 Biopsy of extraocular muscle; for ultrasound guidance please add code 76942 PATHOLOGY Investigation £213
68100 Biopsy of conjunctiva PATHOLOGY Investigation £56
75970 Transcatheter biopsy, radiological supervision and interpretation: Reporting code R5970 PATHOLOGY Intervention includes Investigation (where applicable) £1,625
76948 Ultrasonic guidance for aspiration of ova (ultrasound) (uls): Includes imaging supervision and interpretation; Reporting code R6948. PATHOLOGY Intervention includes Investigation (where applicable) £1,007
80048 Basic metabolic panel chemistry: Includes Calcium (82310) Carbon dioxide (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea Nitrogen (BUN) (84520) PATHOLOGY Investigation £23
80050 General health panel PATHOLOGY Investigation £23
80051 Electrolyte panel: Includes Carbon dioxide (82374) Chloride (82435) Potassium (84132) Sodium (84295) PATHOLOGY Investigation £23
80053 Comprehensive metabolic panel; Includes Albumin, Bilirubin, Calcium, Carbon Dioxide (bicarbonate), Chloride, Creatinine, Glucose, Phosphatase, alkaline, Potassium, Protein, Sodium, Transferase, alanine amino (ALT) (SGPT), aspartate amino (AST) (SGOT), Urea Nitrogen (BUN) PATHOLOGY Investigation £23
80061 Lipid Panel I: Includes Total Cholesterol (82465) Lipoprotein, high density cholesterol (HDL cholesterol) (83718) Triglycerides (84478) PATHOLOGY Investigation £23
80069 Renal function panel: Includes Albumin, Calcium, Carbon dioxide (bicarbonate), Chloride, Creatinine, Glucose, Phosphorus inorganic (phosphate), Potassium, Sodium, Urea nitrogen (BUN) PATHOLOGY Investigation £23
80074 Acute hepatitis panel: Includes Hepatitis A antibody (HAAb) IgM antibody, Hepatitis B core antibody (HbcAb) IgM antibody, Hepatitis B surface antigen (HbsAg), Hepatitis C antibody PATHOLOGY Investigation £23
80076 Hepatic function panel Liver Function Test: Includes Albumin, Bilirubin, Phosphatase, alkaline Protein, Transferase, alanine amino (ALT) (SGPT), aspartate amino (AST) (SGOT) PATHOLOGY Investigation £23
80412 Corticotropic releasing hormone (CRH) stimulation panel: Includes Cortisol (82533) Adrenocorticotropic hormone (ACTH) (82024) PATHOLOGY Investigation £23
80426 Gonadotropin releasing hormone stimulation panel (GnRH test): Includes Follicle stimulating hormone (FSH) (83001) Luteinizing hormone (LH) (83002) PATHOLOGY Investigation £23
80601 QuintilesIMS code:Two-dimensional gel electrophoresis, staining, digitizing and quantification of known protein PATHOLOGY Investigation £17
81000 Urinalysis, by dip stick or tablet reagent for bilirubin, glucose hemoglobin, ketones, leukocytes, nitrite, specific gravity, urobilinogen (urine analysis) (UA); with microscopy, non-automated PATHOLOGY Investigation £19
81001 Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy PATHOLOGY Investigation £19
81002 Urinalysis, by dip stick or tablet reagent for bilirubin, glucose hemoglobin, ketones, leukocytes, nitrite gravity, urobilinogen (urine analysis) (UA); without microscopy, non-automated PATHOLOGY Investigation £19
81005 Urinalysis (urine analysis) (UA); qualitative or semiquantitative, except immunoassays PATHOLOGY Investigation £19
81007 Urinalysis (urine analysis) (UA); bacteriuria screen, except by culture or dipstick PATHOLOGY Investigation £19
81015 Urinalysis (urine analysis) (UA); microscopic only PATHOLOGY Investigation £19
81025 Urine pregnancy test; by visual color comparison methods PATHOLOGY Investigation £10
81240 F2 (prothrombin, coagulation factor II) (eg, hereditary hypercoagulability) gene analysis, 20210G>A variant PATHOLOGY Investigation £40
81245 FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis, internal tandem duplication (ITD) variants (ie, exons 14, 15) PATHOLOGY Investigation £10
81250 G6PC (glucose-6-phosphatase, catalytic subunit) (eg, Glycogen storage disease, Type 1a, von Gierke disease) gene analysis, common variants (eg, R83C, Q347X) PATHOLOGY Investigation £6
81252 GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequence PATHOLOGY Investigation £126
81253 GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; known familial variants PATHOLOGY Investigation £17
81254 GJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (eg, nonsyndromic hearing loss) gene analysis, common variants (eg, 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)]) PATHOLOGY Investigation £17
81260 IKBKAP (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) (eg, familial dysautonomia) gene analysis, common variants (eg, 2507 6T>C, R696P) PATHOLOGY Investigation £10
81270 JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant PATHOLOGY Investigation £10
81287 MGMT (O-6-methylguanine-DNA methyltransferase) (eg, glioblastoma multiforme), methylation analysis PATHOLOGY Investigation £166
81403 Molecular pathology procedure, Level 4 (eg, analysis of single exon by DNA sequence analysis or mutation scanning or duplication/deletion variants of 2-5 exons) PATHOLOGY Investigation £257
81404 Molecular pathology procedure, Level 5 (eg, analysis of 2-5 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 6-10 exons) PATHOLOGY Investigation £166
81405 Molecular pathology procedure, Level 6 (eg, analysis of 6-10 exons by DNA sequence analysis or duplication/deletion variants of 11-25 exons, regionally targeted cytogenomic array analysis) PATHOLOGY Investigation £275
81406 Molecular pathology procedure, Level 7 (eg, analysis of 11-25 exons by DNA sequence analysis or duplication/deletion variants of 26-50 exons) PATHOLOGY Investigation £275
81407 Molecular pathology procedure, Level 8 (eg, analysis of 26-50 exons by DNA sequence analysis or duplication/deletion variants of >50 exons, sequence analysis of multiple genes on one platform) PATHOLOGY Investigation £166
81408 Molecular pathology procedure, Level 9 (eg, analysis of >50 exons in a single gene by DNA sequence analysis) PATHOLOGY Investigation £275
81445 Targeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis, 5-50 genes interrogation for sequence variants and copy number variants or rearrangements, if performed PATHOLOGY Investigation £166
81528 Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool PATHOLOGY Investigation £166
82013 Acetylcholinesterase (Rbc) (AChE) PATHOLOGY Investigation £18
82150 Amylase PATHOLOGY Investigation £10
82232 Beta 2 microglobulin, Beta-2 microglobulin, Alpha 1 microglobulin, Alpha-1 microglobulin; blood, serum, urine PATHOLOGY Investigation £17
82247 Bilirubin; total PATHOLOGY Investigation £13
82248 Bilirubin; direct PATHOLOGY Investigation £13
82373 Carbohydrate deficient transferrin; CDG transferrin isoelectric focusing PATHOLOGY Investigation £17
82374 Carbon dioxide (bicarbonate) (HCO3) PATHOLOGY Investigation £13
82378 Carcinoembryonic antigen (CEA) PATHOLOGY Investigation £13
82435 Chloride, blood PATHOLOGY Investigation £10
82436 Chloride; urine PATHOLOGY Investigation £10
82438 Chloride; other source PATHOLOGY Investigation £10
82465 Cholesterol; total, serum or whole blood PATHOLOGY Investigation £13
82550 Creatine kinase (CK) (CPK); total PATHOLOGY Investigation £10
82552 Creatine kinase (CK) (CPK); isoenzymes PATHOLOGY Investigation £10
82553 Creatine kinase (CK) (CPK) (CK-MB); MB fraction only PATHOLOGY Investigation £10
82554 Creatine kinase (CK) (CPK); isoforms PATHOLOGY Investigation £10
82575 Creatinine clearance; urine, blood, serum PATHOLOGY Investigation £13
82585 Cryofibrinogen PATHOLOGY Investigation £8
82670 Estradiol, oestradiol (Es-1) (Es-2) (E2); blood, serum PATHOLOGY Investigation £15
82715 Fat differential, feces, fecal, stool PATHOLOGY Investigation £8
82759 Galactokinase, RBC PATHOLOGY Investigation £10
82784 Gammaglobulin; IgA, IgD, IgG, IgM each PATHOLOGY Investigation £17
82787 Gammaglobulin; immunoglobulin subclasses, (IgG1, 2, 3 and 4), quantitative immunoglobulin, each PATHOLOGY Investigation £17
82945 Glucose; body fluid, other than blood, serum PATHOLOGY Investigation £6
82947 Glucose; blood, serum (except reagent strip); quantitative PATHOLOGY Investigation £6
82948 Glucose; blood, serum, reagent strip, finger stick test PATHOLOGY Investigation £6
82950 Glucose; post glucose dose (includes glucose) PATHOLOGY Investigation £6
82951 Glucose tolerance test (GTT) (OGTT); Includes glucose dose, fasting glucose and 3 post dose glucose specimens PATHOLOGY Investigation £6
82952 Glucose tolerance test (GTT); each additional beyond three specimens PATHOLOGY Investigation £6
82955 Glucose-6-phosphate dehydrogenase (G6PD) (G-6-PD); quantitative; method by methemoglobin reduction (Brewer's test), modified Bishop (ultraviolet), dye reduction, or ascorbic or fluorescent spot test PATHOLOGY Investigation £6
82962 Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use PATHOLOGY Investigation £6
83001 Gonadotropin; follicle stimulating hormone (FSH) PATHOLOGY Investigation £17
83002 Gonadotropin; luteinizing hormone (LH) PATHOLOGY Investigation £13
83003 Human growth hormone (HGH) (somatotropin) PATHOLOGY Investigation £13
83020 Hemoglobin fractionation and quantitation; electrophoresis (eg, A2, S C, and/or F) PATHOLOGY Investigation £17
83498 Hydroxyprogesterone, 17-d (17-OH Progesterone) PATHOLOGY Investigation £19
83499 Hydroxyprogesterone, 20- PATHOLOGY Investigation £17
83540 Iron (Fe) PATHOLOGY Investigation £10
83550 Iron binding capacity (IBC) (TIBC) PATHOLOGY Investigation £8
83701 Lipoprotein, blood; electrophoretic seperation and quantitation, high resolution fractionation and quantitation of lipoproteins including lipoprotein subclasses when performed PATHOLOGY Investigation £17
83718 Lipoprotein, direct measurement; high density cholesterol (HDL) PATHOLOGY Investigation £13
83719 Lipoprotein, direct measurement; very low density cholesterol (VLDL) PATHOLOGY Investigation £13
83721 Lipoprotein, direct measurement; low density cholesterol (LDL) PATHOLOGY Investigation £13
83735 Magnesium (Mg) PATHOLOGY Investigation £10
83873 Myelin basic protein, cerebrospinal fluid (CSF) PATHOLOGY Investigation £214
83880 Natriuretic peptide, brain nucleic peptide (BNP), substance P; NT Pro BNP PATHOLOGY Investigation £32
83930 Osmolality (Osmolarity); blood, serum PATHOLOGY Investigation £10
83935 Osmolality (Osmolarity); urine PATHOLOGY Investigation £10
83970 Parathormone (parathyroid hormone) (PTH) PATHOLOGY Investigation £33
84144 Progesterone PATHOLOGY Investigation £17
84146 Prolactin (PRL) PATHOLOGY Investigation £17
84152 Prostate specific antigen (PSA); complexed (direct measurement) PATHOLOGY Investigation £17
84153 Prostate specific antigen (PSA); total PATHOLOGY Investigation £17
84154 Prostate specific antigen (PSA); free PATHOLOGY Investigation £23
84165 Protein electrophoresis, protein electrophoretic fractionation and quantitation (SPEP) (UPEP); blood, serum, urine PATHOLOGY Investigation £17
84220 Pyruvate kinase PATHOLOGY Investigation £10
84234 Receptor assay; progesterone PATHOLOGY Investigation £17
84235 Receptor assay; endocrine, other than estrogen or progesterone (specify hormone) PATHOLOGY Investigation £17
84305 Somatomedin, insulin like growth factor, IGF-1, IGF-2 PATHOLOGY Investigation £24
84402 Testosterone (T); free PATHOLOGY Investigation £17
84403 Testosterone (T); total PATHOLOGY Investigation £17
84436 Thyroxine; total (T-4) (T4) (TT4) PATHOLOGY Investigation £13
84439 Thyroxine; free (FT4) (FT-4) (Free T-4) PATHOLOGY Investigation £13
84443 Thyroid stimulating hormone (TSH) PATHOLOGY Investigation £17
84445 Thyroid stimulating immune globulins (TSI) PATHOLOGY Investigation £33
84460 Transferase, alanine aminotransferase (ALT) (ALAT) (SGPT) PATHOLOGY Investigation £10
84466 Transferrin PATHOLOGY Investigation £17
84478 Triglycerides (Tg); blood, serum PATHOLOGY Investigation £10
84479 Thyroid hormone (T3 or T4) uptake or thyroid hormone binding ratio (THBR) PATHOLOGY Investigation £17
84480 Triiodothyronine; total (T3) (T-3) (TT-3) (TT3) PATHOLOGY Investigation £17
84481 Triiodothyronine; free (FT3) (free T-3) (T-3 Uptake) PATHOLOGY Investigation £17
84482 Triiodothyronine; reverse (T3) (T-3) PATHOLOGY Investigation £17
84484 Troponin, quantitative; Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT) PATHOLOGY Investigation £21
84512 Troponin, qualitative PATHOLOGY Investigation £21
84520 Urea nitrogen (BUN); blood, serum; quantitative PATHOLOGY Investigation £13
84525 Urea nitrogen; semiquantitative (eg, reagent strip test) PATHOLOGY Investigation £13
84540 Urea nitrogen; urine PATHOLOGY Investigation £13
84545 Urea nitrogen; clearance PATHOLOGY Investigation £13
84550 Uric acid; blood, serum PATHOLOGY Investigation £10
84560 Uric acid; other source PATHOLOGY Investigation £10
84702 Serum pregnancy, gonadotropin chorionic (hCG) (BetahCG); quantitative PATHOLOGY Investigation £13
84703 Urine pregnancy, gonadotropin chorionic (hCG) (BetahCG); qualitative PATHOLOGY Investigation £10
84830 Ovulation tests by visual color comparison methods for human luteinizing hormone (LH) (Ovutest) PATHOLOGY Investigation £13
85007 Blood count; manual differential WBC count (includes RBC morphology and platelet estimation) PATHOLOGY Investigation £13
85008 Blood count; manual blood smear examination without differential parameters (formerly code 85585) PATHOLOGY Investigation £13
85009 Blood count; differential WBC count, buffy coat PATHOLOGY Investigation £13
85014 Blood count; hematocrit, haematocrit (Hct) (Ht) PATHOLOGY Investigation £13
85018 Blood count; hemoglobin, haemoglobin (Hgb) (Hb) PATHOLOGY Investigation £13
85025 Blood count; hemogram and platelet count, automated and automated complete differential WBC count (CBC), haemogram, hematology, haematology PATHOLOGY Investigation £13
85027 Blood count; complete (CBC), hemogram, haemogram and platelet count, automated (Formerly codes 85021, 85022, 85023) PATHOLOGY Investigation £13
85032 Blood count; manual cell count (erythrocyte, leukocyte, or platelet) each (formerly code 85590) PATHOLOGY Investigation £13
85041 Blood count; red blood cell (RBC) only PATHOLOGY Investigation £13
85044 Blood count; reticulocyte count, manual PATHOLOGY Investigation £13
85045 Blood count; automated, reticulocyte count, flow cytometry PATHOLOGY Investigation £13
85046 Blood count; reticulocytes, hemoglobin, haemoglobin concentration; automated, including one or more cellular parameters, immature reticulocyte fraction, reticulocyte volume, direct measurement PATHOLOGY Investigation £13
85048 Blood count; white blood cell (WBC), leukocyte count, leucocyte count, neutrophil count; automated PATHOLOGY Investigation £13
85049 Blood count; platelet count; thrombocyte count, automated (formerly codes 85595, 85598) PATHOLOGY Investigation £13
85055 Reticulated platelet assay PATHOLOGY Investigation £13
85060 Blood smear; peripheral, interpretation by physician PATHOLOGY Investigation £230
85097 Bone marrow, smear interpretation PATHOLOGY Investigation £230
85210 Clotting; factor II, prothrombin, specific PATHOLOGY Investigation £22
85220 Clotting; factor V, AcG or proaccelerin, labile factor, leiden factor PATHOLOGY Investigation £22
85230 Clotting; factor VII, proconvertin, stable factor PATHOLOGY Investigation £22
85240 Clotting; factor VIII, AHG PATHOLOGY Investigation £22
85244 Clotting; factor VIII related antigen PATHOLOGY Investigation £22
85245 Clotting; factor VIII, VW factor, Von Willebrand's factor, ristocetin cofactor PATHOLOGY Investigation £22
85246 Clotting; factor VIII, VW factor antigen, Von Willebrand's factor antigen PATHOLOGY Investigation £22
85247 Clotting; factor VIII, Von Willebrand's factor, multimetric analysis PATHOLOGY Investigation £22
85250 Clotting; factor IX, PTC,Christmas PATHOLOGY Investigation £22
85260 Clotting; factor X, Stuart-Prower PATHOLOGY Investigation £22
85270 Clotting; factor XI, PTA PATHOLOGY Investigation £22
85280 Clotting; factor XII, Hageman PATHOLOGY Investigation £22
85290 Clotting; factor XIII, fibrin stabilizing PATHOLOGY Investigation £22
85292 Clotting; prekallikrein assay, Fletcher factor assay PATHOLOGY Investigation £20
85293 Clotting; high molecular weight kininogen assay, Fitzgerald factor assay PATHOLOGY Investigation £20
85300 Clotting inhibitors or anticoagulants; antithrombin III PATHOLOGY Investigation £20
85302 Clotting inhibitors or anticoagulants; protein C, antigen PATHOLOGY Investigation £20
85305 Clotting inhibitors or anticoagulants; protein S, total and free PATHOLOGY Investigation £20
85378 Fibrin degradation products, D-dimer PATHOLOGY Investigation £8
85384 Fibrinogen; activity PATHOLOGY Investigation £8
85385 Fibrinogen; antigen PATHOLOGY Investigation £43
85610 Prothrombin time (PT) (Formerly code 85600) PATHOLOGY Investigation £20
85651 Sedimentation rate, erythrocyte (ESR) (SED); non-automated PATHOLOGY Investigation £8
85670 Thrombin time; plasma (TT) (TCT) (Thrombin clotting time) PATHOLOGY Investigation £20
85705 Thromboplastin inhibition; tissue (TTI) PATHOLOGY Investigation £20
85730 Thromboplastin time, partial (PTT) (aPTT); plasma or whole blood, serum PATHOLOGY Investigation £20
85732 Thromboplastin time, partial (PTT); substitution, plasma fractions, each PATHOLOGY Investigation £20
85810 Viscosity, viscosimeter PATHOLOGY Investigation £20
86140 C-reactive protein (CRP) PATHOLOGY Investigation £13
86141 C-reactive protein; high sensitivity (hsCRP) PATHOLOGY Investigation £13
86146 Beta 2 Glycoprotein I antibody, each PATHOLOGY Investigation £18
86225 Deoxyribonucleic acid (DNA) antibody (anti-D Nase-B); anti ds DNA PATHOLOGY Investigation £166
86300 Immunoassay for tumor antigen, quantitative; CA 15-3, CA 27-29, CA 19-9, CA 125, CA 50, CA 72-4, CA 549, each antigen PATHOLOGY Investigation £17
86301 Immunoassay for tumor antigen, quantitative; CA 19-9 PATHOLOGY Investigation £17
86304 Immunoassay for tumor antigen; quantitative, CA 125 PATHOLOGY Investigation £17
86316 Immunoassay for tumor antigen, tumor markers, quantitative; (eg, CA 15-3, CA 19-9, CA 50, CA 72-4, CA 125, CA 195, CA 242, CA 549) PATHOLOGY Investigation £17
86320 Immunoelectrophoresis; blood, serum PATHOLOGY Investigation £17
86325 Immunoelectrophoresis; other fluids (eg, urine, cerebrospinal fluid (CSF)) with concentration PATHOLOGY Investigation £126
86334 Immunofixation electrophoresis PATHOLOGY Investigation £34
86335 Immunofixation electrophoresis; serum; other fluids with concentration (eg, urine, CSF); or 24-hour urine; including monoclonal protein, M-protein PATHOLOGY Investigation £126
86340 Intrinsic factor antibodies (anti-IgF-I antibodies) PATHOLOGY Investigation £17
86359 T cells; total count PATHOLOGY Investigation £20
86360 T cells; absolute CD4 and CD8 count, including ratio PATHOLOGY Investigation £98
86361 T cells; absolute CD4 count (CD 4) (CD-4) PATHOLOGY Investigation £98
86367 Stem cells ( ie, CD34, CD 34, CD-34), total count using the different ways of writing CD34 (formerly code 86364) PATHOLOGY Investigation £98
86376 Microsomal antibodies (eg, thyroid or liver-kidney); each antibody (e.g. antimicrosomal, anti-liver-kidney microsomal (LKM)) PATHOLOGY Investigation £33
86631 Antibody; chlamydia, IgG, IgA PATHOLOGY Investigation £12
86632 Antibody; chlamydia, IgM PATHOLOGY Investigation £12
86644 Antibody; cytomegalovirus, IgG (CMV) PATHOLOGY Investigation £89
86645 Antibody; cytomegalovirus, IgM (CMV) PATHOLOGY Investigation £89
86880 Antihuman globulin test (Coombs test); direct PATHOLOGY Investigation £11
86885 Antihuman globulin test (Coombs test); indirect PATHOLOGY Investigation £11
87149 Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probed PATHOLOGY Investigation £166
87153 Culture, typing; identification by nucleic acid sequencing method, each isolate (eg, sequencing of the 16S rRNA gene) PATHOLOGY Investigation £166
87177 Ova and parasites, direct smears; concentration and identification PATHOLOGY Investigation £230
87181 Susceptibility/sensitivity studies, antibiotic; agar dilution method, agar diffusion method, per agent (eg, antibiotic gradient strip) PATHOLOGY Investigation £29
87184 Susceptibility/sensitivity studies, antibiotic; disk method, disc method, per plate (12 or fewer agents) PATHOLOGY Investigation £29
87186 Susceptibility/sensitivity studies, antibiotic; microdilution or agar dilution (minimum inhibitory concentration (MIC) or breakpoint), each multi-antimicrobial, per plate PATHOLOGY Investigation £29
87187 Susceptibility/sensitivity studies, antibiotic; microdilution or agar dilution, minimum lethal concentration (MLC), each plate PATHOLOGY Investigation £29
87188 Susceptibility/sensitivity studies, antibiotic; macrobroth dilution method, each agent PATHOLOGY Investigation £29
87205 Smear, primary source with interpretation; Gram Stain or Gi bacteria, fungi, or cell types PATHOLOGY Investigation £230
87206 Smear, primary source with interpretation; fluorescent stain for bacteria, fungi, parasites, viruses or cell types PATHOLOGY Investigation £230
87207 Smear, primary source with interpretation; special stain bodies or intracellular parasites (eg, malaria, coccidia microsporidia, cytomegalovirus, herpes viruses) PATHOLOGY Investigation £230
87210 Smear, primary source with interpretation; wet mount agents (eg, saline, India ink, KOH preps) PATHOLOGY Investigation £230
87495 Infectious agent detection by nucleic acid (DNA or RNA); cytomegalovirus (CMV), direct probe technique PATHOLOGY Investigation £48
87497 Infectious agent detection by nucleic acid (DNA or RNA); cytomegalovirus (CMV), quantification PATHOLOGY Investigation £48
87506 Infectious agent detection by nucleic acid (DNA or RNA); Bartonella henselae and Bartonella Quintana, direct probe technique ; gastrointestinal pathogen, includes multiplex reverse transcription. PATHOLOGY Investigation £48
87510 Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe technique PATHOLOGY Investigation £48
87516 Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe technique PATHOLOGY Investigation £48
87517 Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification PATHOLOGY Investigation £48
87521 Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C amplified probe technique PATHOLOGY Investigation £48
87522 Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C quantification; HCV RNA, quantification PATHOLOGY Investigation £48
87528 Infectious agent detection by nucleic acid (DNA or RNA); Herpes simplex virus, direct probe technique PATHOLOGY Investigation £48
87534 Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, direct probe technique PATHOLOGY Investigation £48
87535 Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, amplified probe technique, uncludes reverse transcription when performed PATHOLOGY Investigation £48
87536 Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed PATHOLOGY Investigation £48
87537 Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, direct probe technique PATHOLOGY Investigation £48
87555 Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria tuberculosis, direct probe technique PATHOLOGY Investigation £48
87556 Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria tuberculosis, amplified probe technique PATHOLOGY Investigation £48
87557 Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria tuberculosis, quantification PATHOLOGY Investigation £48
87623 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), low-risk types (eg, 6, 11, 42, 43, 44) PATHOLOGY Investigation £48
87624 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 ) PATHOLOGY Investigation £48
87625 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed PATHOLOGY Investigation £48
87631 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus multiplex reverse transcription and amplified probe technique, multiple types or subtypes, 3-5 targets PATHOLOGY Investigation £48
87632 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus multiplex reverse transcription and amplified probe technique, multiple types or subtypes, 6-11 targets PATHOLOGY Investigation £48
87633 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus, multiplex reverse transcription and amplified probe technique, multiple types or subtypes, 12-25 targets PATHOLOGY Investigation £48
87641 Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique PATHOLOGY Investigation £48
87798 Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism (e.g. PCR BK virus, PCR JC virus); urine, plasma, or serum; quantitative PATHOLOGY Investigation £48
87901 Infectious agent genotype analysis by nucleic acid (DNA or RNA) HIV 1; reverse transcriptase and protease PATHOLOGY Investigation £166
87902 Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus PATHOLOGY Investigation £166
87903 Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; first 10 drugs tested PATHOLOGY Investigation £166
87912 Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus PATHOLOGY Investigation £166
88108 Cytopathology, concentration technique, smears and interpretation (Saccomanno technique) PATHOLOGY Investigation £230
88141 Cytopathology, cervical or vaginal, PAP smear: Includes interpretation PATHOLOGY Investigation £230
88160 Cytopathology, smears excluding cervical or vaginal, any other source; screening and interpretation. PATHOLOGY Investigation £230
88182 Flow cytometry; cytoplasmic or nuclear marker; cell cycle or DNA analysis (Formerly code 88180) PATHOLOGY Investigation £166
88271 Molecular cytogenetics; DNA probe (eg, FISH) PATHOLOGY Investigation £166
88313 Special stains;Group II, all other, except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry. Reporting code R8313 PATHOLOGY Investigation £22
88342 Immunohistochemistry separately identifiable antibody per block, cytologic preparation, or hematologic smear; first separately identifiable antibody per slide: Reporting code R8342. PATHOLOGY Investigation £230
88399 Unlisted surgical pathology procedure (e.g. tumor biopsy) PATHOLOGY Investigation £144
88720 Bilirubin, total, transcutaneous PATHOLOGY Investigation £13
89051 Cell count, miscellaneous body fluids (eg, cerebrospinal fluid (CSF), joint fluid), except blood, serum; with differential count PATHOLOGY Investigation £8
89190 Eosinophil smear, eosinophil count; nasal, sputum, urine PATHOLOGY Investigation £230
93268 Auto activated electrocardiographic rhythm event recording with symptom-related memory loop with remote download capability up to 30 days; includes transmission, physician review and interpretation PATHOLOGY Investigation £304
93270 External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days. 24-hour attended monitoring; recording (includes connection, recording, and disconnection) PATHOLOGY Investigation £304
93271 External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days. 24-hour attended monitoring; transmission download and analysis PATHOLOGY Investigation £304
93272 External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days. 24-hour attended monitoring; physician review and interpretation PATHOLOGY Investigation £304
93505 Endomyocardial biopsy, myocardial biopsy PATHOLOGY Investigation £213
95250 Ambulatory glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for 72 hours; placement, calibration, training, removal and recording. Use 95251 for interpretation and report PATHOLOGY Investigation £139
95251 Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; interpretation and report PATHOLOGY Investigation £139
81400-11 F7 (coagulation factor VII [serum prothrombin conversion accelerator])(eg, hereditary hypercoagulability), R353Q variant. . PATHOLOGY Investigation £20
81400-12 FGB (fibrinogen beta chain) (eg, hereditary ischemic heart disease), -455G>A varian. . PATHOLOGY Investigation £8
81400-16 GNE (glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosaminekinase) (eg, inclusion body myopathy 2 [IBM2], Nonaka myopathy),M712T variant. . PATHOLOGY Investigation £10
81400-17 Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa],antigen CD61 [GPIIIa]), HPA-1a/b (L33P). . PATHOLOGY Investigation £17
81400-18 Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]), HPA-2a/b(T145M). . PATHOLOGY Investigation £17
81400-19 Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]), HPA-3a/b (I843S). . PATHOLOGY Investigation £17
81400-20 Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]), HPA-4a/b (R143Q). . PATHOLOGY Investigation £17
81400-21 Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa]), HPA-5a/b (K505E). . PATHOLOGY Investigation £17
81400-22 Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa]), HPA-6a/b (R489Q). . PATHOLOGY Investigation £17
81400-23 Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]), HPA-9a/b (V837M). . PATHOLOGY Investigation £17
81400-24 Human Platelet Antigen 15 genotyping (HPA-15), CD109 (CD109molecule) (eg, neonatal alloimmune thrombocytopenia [NAIT], posttransfusion purpura), HPA-15a/b (S682Y). . PATHOLOGY Investigation £17
81400-27 LCT (lactase-phlorizin hydrolase) (eg, lactose intolerance), 13910 C>Tvariant. . PATHOLOGY Investigation £10
81401-02 ABL (c-abl oncogene 1, receptor tyrosine kinase) (eg, acquired imatinib resistance), T315I variant PATHOLOGY Investigation £10
81401-04 ADRB2 (adrenergic beta-2 receptor surface) (eg, drug metabolism), common variants (eg, G16R, Q27E) PATHOLOGY Investigation £17
81401-06 APOB (apolipoprotein B) (eg, familial hypercholesterolemia type B), common variants (eg, R3500Q, R3500W) PATHOLOGY Investigation £13
81401-25 DMPK (dystrophia myotonica-protein kinase) (eg, myotonic dystrophy,type 1), evaluation to detect abnormal (eg, expanded) alleles. PATHOLOGY Investigation £10
81401-51 LRRK2 (leucine-rich repeat kinase 2) (eg, Parkinson disease), commonvariants (eg, R1441G, G2019S, I2020T). PATHOLOGY Investigation £10
81401-67 PAX8/PPARG (t(2;3) (q13;p25)) (eg, follicular thyroid carcinoma),translocation analysis. PATHOLOGY Investigation £33
81402-04 ESR1/PGR (receptor 1/progesterone receptor) ratio (eg, breast cancer). Please reference general code 81402. PATHOLOGY Investigation £24
81403-01 ABL1 (c-abl oncogene 1, receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), variants in the kinase domain. Please reference general code 81403. PATHOLOGY Investigation £10
81403-08 DNMT3A (DNA [cytosine-5-]-methyltransferase 3 alpha) (eg, acute myeloid leukemia), targeted sequence analysis (eg, exon 23). Please reference general code 81403. PATHOLOGY Investigation £166
81403-18 JAK2 (Janus kinase 2) (eg, myeloproliferative disorder), exon 12sequence and exon 13 sequence, if Performed PATHOLOGY Investigation £10
81403-23 Known familial variant not otherwise specified, for gene listed in Tier 1 or Tier 2, DNA sequence analysis, each variant exon. Please reference general code 81403. PATHOLOGY Investigation £166
81404-08 C10orf2 (chromosome 10 open reading frame 2) (eg, mitochondrial DNAdepletion syndrome), full gene sequence PATHOLOGY Investigation £275
81404-10 CD40LG (CD40 ligand) (eg, X-linked hyper IgM syndrome), full gene sequence. Please reference general code 81404. PATHOLOGY Investigation £126
81404-11 CDKN2A (cyclin-dependent kinase inhibitor 2A)(eg, CDKN2A-related cutaneous malignant melanoma, familial atypicalmole-malignant melanoma syndrome), full gene sequence PATHOLOGY Investigation £119
81404-18 DMPK (dystrophia myotonica-protein kinase) (eg, myotonic dystrophytype 1), characterization of abnormal (eg, expanded) alleles. Please reference general code 81404. PATHOLOGY Investigation £119
81404-66 RET (ret proto-oncogene) (eg, multiple endocrine neoplasia, type 2B andfamilial medullary thyroid carcinoma), common variants (eg, M918T,2647_2648delinsTT, A883F). Please reference general code 81404. PATHOLOGY Investigation £142
81404-75 SLC16A2 (solute carrier family 16, member 2 [thyroid hormonetransporter]) (eg, specific thyroidhormone cell transporter deficiency, Allan-Herndon-Dudley syndrome),duplication/deletion analysis. PATHOLOGY Investigation £142
81404-80 STK11 (serine/threonine kinase 11) (eg, Peutz-Jeghers syndrome),duplication/deletion analysis PATHOLOGY Investigation £10
81405-107 SLC16A2 (solute carrier family 16, member 2 [thyroid hormonetransporter]) (eg, specific thyroid hormone cell transporterdeficiency, Allan-Herndon-Dudley syndrome), full gene sequence PATHOLOGY Investigation £142
81405-11 BMPR2 (bone morphogenetic protein receptor, type II[serine/threonine kinase]) (eg, heritable pulmonary arterial hypertension), duplication/deletion analysis PATHOLOGY Investigation £119
81405-110 SLC2A1 (solute carrier family 2 [facilitated glucose transporter],member 1) (eg, glucose transporter type 1 [GLUT 1] deficiencysyndrome), full gene sequence. Please reference general code 81405. PATHOLOGY Investigation £115
81405-117 STK11 (serine/threonine kinase 11) (eg, Peutz-Jeghers syndrome),full gene sequence PATHOLOGY Investigation £119
81405-119 TARDBP (TAR DNA binding protein) (eg, amyotrophic lateral sclerosis), full gene sequence PATHOLOGY Investigation £275
81405-124 THRB (thyroid hormone receptor, beta) (eg, thyroid hormoneresistance, thyroid hormone beta receptor deficiency), full gene sequence or targeted sequence analysis of >5 exons. PATHOLOGY Investigation £142
81405-125 TK2 (thymidine kinase 2, mitochondrial) (eg, mitochondrial DNAdepletion syndrome), full gene sequence PATHOLOGY Investigation £175
81405-126 TNNI3 (troponin I, type 3 [cardiac]) (eg, familial hypertrophic cardiomyopathy), full gene sequence PATHOLOGY Investigation £131
81405-127 TNNC1 (troponin C type 1 [slow]) (eg, hypertrophic cardiomyopathy or dilated cardiomyopathy), full gene sequence PATHOLOGY Investigation £131
81405-131 TYMP (thymidine phosphorylase) (eg, mitochondrial DNA depletionsyndrome), full gene sequence PATHOLOGY Investigation £275
81405-14 CDKL5 (cyclin-dependent kinase-like 5) (eg, earlyinfantile epileptic encephalopathy), duplication/deletion analysis. Please reference general code 81405. PATHOLOGY Investigation £119
81405-28 DGUOK (deoxyguanosine kinase) (eg, hepatocerebral mitochondrial DNA depletion syndrome), full gene sequence PATHOLOGY Investigation £175
81405-29 DHCR7 (7-dehydrocholesterol reductase) (eg, Smith-Lemli-Opitzsyndrome), full gene sequence PATHOLOGY Investigation £122
81405-61 MPV17 (MpV17 mitochondrial inner membrane protein) (eg,mitochondrial DNA depletion syndrome), full gene sequence PATHOLOGY Investigation £275
81405-77 OTC (ornithine carbamoyltransferase) (eg, ornithine transcarbamylasedeficiency), full gene sequence PATHOLOGY Investigation £119
81405-84 PINK1 (PTEN induced putative kinase 1) (eg, Parkinson disease), full gene sequence PATHOLOGY Investigation £119
81405-93 RET (ret proto-oncogene) (eg, multiple endocrine neoplasia, type 2A and familial medullary thyroid carcinoma), targeted sequence analysis (eg,exons 10, 11, 13-16) PATHOLOGY Investigation £142
81405-95 RRM2B (ribonucleotide reductase M2 B [TP53 inducible]) (eg,mitochondrial DNA depletion), full gene sequence PATHOLOGY Investigation £275
81406-112 POLG (polymerase [DNA directed], gamma) (eg, Alpers-Huttenlochersyndrome, autosomal dominant progressive external ophthalmoplegia), full gene sequence PATHOLOGY Investigation £275
81406-116 PRKAG2 (protein kinase, AMP-activated, gamma 2 non-catalytic subunit) full gene sequence PATHOLOGY Investigation £119
81406-117 PRKCG (protein kinase C, gamma) (eg, spinocerebellar ataxia), full gene sequence (sodium channel,voltage-gated, type IV, alpha subunit) (eg,hyperkalemic periodic paralysis), full gene sequence PATHOLOGY Investigation £119
81406-134 SLC37A4 (solute carrier family 37 [glucose-6-phosphate transporter],member 4) (eg, glycogen storage disease type Ib), full gene sequence PATHOLOGY Investigation £115
81406-144 TNNT2 (troponin T, type 2 [cardiac]) (eg, familial hypertrophiccardiomyopathy), full gene sequence PATHOLOGY Investigation £131
81406-16 BMPR2 (bone morphogenetic protein receptor, type II [serine/threoninekinase]) (eg, heritable pulmonary arterial hypertension), full gene sequence PATHOLOGY Investigation £119
81406-19 BTK (Bruton agammaglobulinemia tyrosine kinase) (eg, X-linked agammaglobulinemia), full gene sequence PATHOLOGY Investigation £119
81406-24 CDKL5 (cyclin-dependent kinase-like 5) (eg, early infantile epilepticencephalopathy), full gene sequence PATHOLOGY Investigation £119
81406-25 CLCN1 (chloride channel 1, skeletal muscle) (eg, myotonia congenita), full gene sequence PATHOLOGY Investigation £119
81406-26 CLCNKB (chloride channel, voltage-sensitive Kb) (eg, Bartter syndrome 3 and 4b), full gene sequence PATHOLOGY Investigation £119
81406-47 FASTKD2 (FAST kinase domains 2) (eg, mitochondrial respiratory chaincomplex IV deficiency), full gene sequence PATHOLOGY Investigation £119
81406-56 GCK (glucokinase [hexokinase 4]) (eg, maturity-onset diabetes of theyoung [MODY]), full gene sequence PATHOLOGY Investigation £119
81406-58 GNE (glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosaminekinase) (eg, inclusion body myopathy 2 [IBM2], Nonaka myopathy), fullgene sequence PATHOLOGY Investigation £119
81406-80 MAP2K1 (mitogen-activated protein kinase 1) (eg, cardiofaciocutaneoussyndrome), full gene sequence PATHOLOGY Investigation £119
81406-81 MAP2K2 (mitogen-activated protein kinase 2) (eg, cardiofaciocutaneoussyndrome), full gene sequence PATHOLOGY Investigation £119
81407-06 CHD7 (chromodomain helicase DNA binding protein 7) (eg, CHARGEsyndrome), full gene sequence PATHOLOGY Investigation £275
81407-31 SLC12A1 (solute carrier family 12 [sodium/potassium/chloride transporters], member 1) (eg, Bartter syndrome), full gene sequence. Please reference general code 81407. PATHOLOGY Investigation £119
81407-32 SLC12A3 (solute carrier family 12 [sodium/chloride transporters], member 3) (eg, Gitelman syndrome), full gene sequence PATHOLOGY Investigation £119
81408-17 LRRK2 (leucine-rich repeat kinase 2) (eg, Parkinson disease), full gene sequence. Please reference general code 81408. PATHOLOGY Investigation £10
INR International Normalized Ratio (INR) PATHOLOGY Investigation £12
NIHR_INV_025 Skin Scrape PATHOLOGY Investigation £673
NIHR_INV_026 Brochial wash PATHOLOGY Investigation £636
NIHR_INV_027 Paraprotein Measurement (Densitometry) PATHOLOGY Investigation £17
T0060 Thyroid panel, thyroid function tests - Includes triiodothyronine, T3 (84480) thyroxine, T4 (84436) thyroid stimulating hormone, TSH (84443) (Formerly QuintilesIMS code 80060) PATHOLOGY Investigation £23
T0065 Lipid Panel II: Includes Total Cholesterol, Lipoprotein, high density cholesterol (HDL cholesterol), low density cholesterol (LDL Cholesterol), Triglycerides, Apolipoprotein (Apo A-1) (Apo B) (Apo E) PATHOLOGY Investigation £23
T0073 Hepatitis panel - Includes hepatitis B and C only (Formerly QuintilesIMS code 80073) PATHOLOGY Investigation £12
T0090 TORCH antibody panel: Includes Antibody, cytomegalovirus (CMV) (86644) Antibody, herpes simplex, non-specific type test (86694) Antibody, rubella (86762) Antibody, toxoplasma (86777) PATHOLOGY Investigation £12
T0095 Endocrine panel - Includes cortisol (82533) human growth hormone, HGH (83003) prolactin, PRL (84146) adrenocorticotropic hormone, ACTH (82024) (Formerly QuintilesIMS code 80095) PATHOLOGY Investigation £39
T0217 Anesthesia for all procedures on esophagus, thyroid, larynx, trachea and lymphatic system of neck; needle biopsy of thyroid PATHOLOGY Intervention includes Investigation (where applicable) £1,085
T0719 Cardiac Telemetry; continuous electronic monitoring of heart rhythm and heart rate, with or without blood pressure monitoring; 0-6 hours PATHOLOGY Investigation £110
T0720 Cardiac Telemetry; continuous electronic monitoring of heart rhythm and heart rate, with or without blood pressure monitoring; up to 24 hours: Includes interpretation and report PATHOLOGY Investigation £110
T0908 Cystic Fibrosis Screen by PCR; Oligonucleotide Ligation: ACOG Panel PATHOLOGY Investigation £92
T0911 Anemia Profile Panel including reticulocyte count, Iron with TIBC, Vitamin B12, CBC with differential, Ferritin, Folate, Folic Acid PATHOLOGY Investigation £23
T1013 Comprehensive Anemia Profile, Anaemia Panel including: reticulocyt count, Iron with TIBC, Vitamin B12, CBC with differential, ferritin, folate, folic acid. PATHOLOGY Investigation £23
T1103 Autoimmune Panel, up to five indicators PATHOLOGY Investigation £23
T1104 Autoimmune Panel, up to 10 indicators PATHOLOGY Investigation £47
T1105 Autoimmune Panel, up to 15 indicators PATHOLOGY Investigation £70
T1201 KRAS gene, 7 mutation panel, Tumor ; c-K-ras2 protein; c-K-ras protein; KI-RAS; Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog: For interpretation and report use RT201 PATHOLOGY Investigation £23
T1203 Jak2 (V617F) Mutation by PCR PATHOLOGY Investigation £92
T1208 Two-dimensional gel electrophoresis, staining, digitizing and quantification of known protein PATHOLOGY Investigation £17
T4186 IgF binding protein 1 (IGFBP-1) (IGFBP1) (IGFBP 1) (Formerly QuintilesIMS code 84186) PATHOLOGY Investigation £17
T4187 IgF binding protein 3 (IGFBP-3) (IGFBP3) (IGFBP 3) (Formerly QuintilesIMS code 84187) PATHOLOGY Investigation £17
T5209 Clotting; factor I, fibrinogen (Formerly QuintilesIMS code 85209) PATHOLOGY Investigation £27
T6362 T cells; absolute CD8 count (CD 8) (CD-8) (Formerly QuintilesIMS code 86362) PATHOLOGY Investigation £20
T6363 CD18, CD 18, CD-18 (Formerly QuintilesIMS code 86363) PATHOLOGY Investigation £20
T6365 Earliest B cells CD19, CD 19, CD-19 (Formerly QuintilesIMS code 86365) PATHOLOGY Investigation £20
T9013 Biopsy; Staining and preparation of the slides including shipping and handling (Formerly QuintilesIMS code 99013) PATHOLOGY Investigation £54
T9999 Unlisted laboratory panel, safety labs, routine laboratory tests; chemistry, chemistries, smac, hemogram, hematology, CBC, urinalysis, urine analysis (Formerly QuintilesIMS code 89999) PATHOLOGY Investigation £23
TM030 Biomarker, Intercellular adhesion molecule 1 (ICAM-1) (sICAM-1) (CD54) (CD 54) (CD-54) (Formerly QuintilesIMS code BM030) PATHOLOGY Investigation £20
TM035 Biomarker, Dipeptidyl peptidase-IV, dipeptidyl peptidase 4 (DPP-IV) (DPP IV) (CD26) (CD 26) (CD-26) (Formerly QuintilesIMS code BM035) PATHOLOGY Investigation £20
TM038 Biomarker, Prothrombin fragments 1 and 2, Prot 1+2 (Formerly QuintilesIMS code BM038) PATHOLOGY Investigation £20
TM039 Biomarker, Tumor block immunohistochemistry (IHC), oncology marker (Formerly QuintilesIMS code BM039) PATHOLOGY Investigation £80
TM040 Biomarker, Tumor block immunohistochemistry (IHC), oncology marker with imaging (Formerly QuintilesIMS code BM040) PATHOLOGY Investigation £80
70200 X-RAY 1 view RADIOLOGY Investigation £61
70220 X-RAY 3 views RADIOLOGY Investigation £183
70300 X-RAY Per view RADIOLOGY Investigation £43
70450 CT Scan without contrast 1 site RADIOLOGY Investigation £169
70460 CT Scan with contrast 1 site RADIOLOGY Investigation £257
70540 MRI/MRA with or without contrast 1 site RADIOLOGY Investigation £491
70554 MRI Complex RADIOLOGY Investigation £635
70555 Magnetic resonance imaging, brain, functional MRI; requiring physician or psychologist administration of entire neurofunctional: Reporting code R0555 RADIOLOGY Intervention includes Investigation (where applicable) £1,433
71020 X-RAY 2 views RADIOLOGY Investigation £122
71023 X-RAY Complex (Biopsy guidance or Skeletal Survey) RADIOLOGY Investigation £366
71555 MRI/MRA with contrast 4 sites or more/ whole body RADIOLOGY Investigation £1,155
72050 X-RAY 5 views RADIOLOGY Investigation £305
72052 X-RAY 6 views RADIOLOGY Investigation £366
72141 MRI/MRA with or without contrast 1 site RADIOLOGY Investigation £491
72240 Myelography RADIOLOGY Investigation £274
72295 Diskography, lumbar, radiological supervision, nucleography RADIOLOGY Investigation £181
73564 X-RAY 4 views RADIOLOGY Investigation £244
74176 CT Scan without contrast 2 Sites RADIOLOGY Investigation £267
74177 CT Scan with contrast 4 sites or more/ whole body RADIOLOGY Investigation £514
74246 X-RAY with contast per visit RADIOLOGY Investigation £183
74290 Cystography RADIOLOGY Investigation £601
74420 Urography, retrograde, with or without KUB; Reporting code R4420 RADIOLOGY Investigation £138
75561 MRI Complex - novel sequences requiring development RADIOLOGY Investigation £635
75635 CT Scan with contrast 3 sites RADIOLOGY Investigation £378
75820 X-RAY Venography RADIOLOGY Investigation £92
76442 Ultrasound per site RADIOLOGY Investigation £92
76498 MRI/MRA without contrast 4 sites or more/ whole body RADIOLOGY Investigation £1,027
T1009 CT Scan without contrast 4 sites or more/ whole body RADIOLOGY Investigation £418
T1021 Ultrasound Complex / Developmental / Contrast-enhanced Ultrasound RADIOLOGY Investigation £204
T4169 CT Scan with contrast 2 Sites RADIOLOGY Investigation £337
77261 Therapeutic radiology treatment planning; simple RADIOTHERAPY Investigation £463
77262 Therapeutic radiology treatment planning; intermediate RADIOTHERAPY Investigation £700
77263 Therapeutic radiology treatment planning; complex RADIOTHERAPY Investigation £2,168
77280 Therapeutic radiology simulation-aided field setting; simple; For Interpretation and Report please use code R7280 RADIOTHERAPY Investigation £628
77285 Therapeutic radiology simulation-aided field setting; intermediate; For Interpretation and Report please use code R7285 RADIOTHERAPY Investigation £1,074
77290 Therapeutic radiology simulation-aided field setting; complex; For Interpretation and Report please use code R7290 RADIOTHERAPY Investigation £3,199
77300 Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose RADIOTHERAPY Investigation £3,199
NIHR_INV_032 Deliver a Fraction of Treatment on a Superficial or Orthovoltage Machine RADIOTHERAPY Investigation £182
NIHR_INV_033 Deliver a Fraction of Treatment on a Megavoltage Machine RADIOTHERAPY Investigation £234
NIHR_INV_034 Deliver a Fraction of Complex Treatment on a Megavoltage Machine RADIOTHERAPY Investigation £300
NIHR_INV_035 Deliver a Fraction of Radiotherapy on a Megavoltage Machine using General Anaesthetic RADIOTHERAPY Investigation £545
NIHR_INV_036 Deliver a Fraction of Total Body Irradiation RADIOTHERAPY Investigation £861
NIHR_INV_037 Deliver a Fraction of Adaptive Radiotherapy on a Megavoltage Machine RADIOTHERAPY Investigation £391
NIHR_INV_038 Preparation for Intensity Modulated Radiation Therapy RADIOTHERAPY Investigation £2,399
NIHR_INV_039 Preparation for Intensity Modulated Radiation Therapy, with Technical Support RADIOTHERAPY Investigation £3,199
NIHR_INV_040 Preparation for Total Body Irradiation RADIOTHERAPY Investigation £2,168
NIHR_INV_041 Preparation for Total Body Irradiation, with Technical Support RADIOTHERAPY Investigation £2,168
NIHR_INV_042 Preparation for Hemi Body Irradiation RADIOTHERAPY Investigation £671
NIHR_INV_043 Preparation for Simple Radiotherapy with Imaging and Dosimetry RADIOTHERAPY Investigation £964
NIHR_INV_044 Preparation for Simple Radiotherapy with Imaging and Dosimetry, with Technical Support RADIOTHERAPY Investigation £1,643
NIHR_INV_045 Preparation for Simple Radiotherapy with Imaging and Simple Calculation RADIOTHERAPY Investigation £700
NIHR_INV_046 Preparation for Simple Radiotherapy with Imaging and Simple Calculation, with Technical Support RADIOTHERAPY Investigation £1,074
NIHR_INV_047 Preparation for Superficial Radiotherapy with Simple Calculation RADIOTHERAPY Investigation £463
NIHR_INV_048 Preparation for Superficial Radiotherapy with Simple Calculation, with Technical Support RADIOTHERAPY Investigation £628
NIHR_INV_049 Preparation for Complex Conformal Radiotherapy RADIOTHERAPY Investigation £1,445
NIHR_INV_050 Preparation for Complex Conformal Radiotherapy, with Technical Support RADIOTHERAPY Investigation £1,926
NIHR_INV_051 All additionally required reports and interpretations (over and above standard care) per report REPORTING Investigation £117
82800 Gases, blood, pH only SPECIALIST MEDICINE Investigation £58
82803 Gases, blood, arterial blood gases (any combination of pH, pCO2, pO2, CO2, HCO3) SPECIALIST MEDICINE Investigation £58
82805 Gases, blood, arterial blood gases (any combination of pH, pCO2 calculated O2 saturation); with O2 saturation, by direct measurement except pulse oximetry SPECIALIST MEDICINE Investigation £58
82810 Gases, blood, O2 saturation only; by direct measurement, except pulse oximetry SPECIALIST MEDICINE Investigation £58
92512 Nasal function studies (eg, rhinomanometry, rhinoprobe, nasal CDA) SPECIALIST MEDICINE Investigation £58
94010 Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), forced expiratory volume (FEV), with or without maximal voluntary ventilation (MVV). Reporting code R4010. SPECIALIST MEDICINE Investigation £215
94060 Bronchospasm evaluation: spirometry with reversibility, pre- and post-bronchodilator administration (aerosol or parenteral), pulmonary function test (PFT), lung function test SPECIALIST MEDICINE Investigation £95
94150 Total vital capacity, pulmonary function test (PFT), lung function test SPECIALIST MEDICINE Investigation £88
94729 Diffusing capacity (eg, carbon monoxide, membrane) SPECIALIST MEDICINE Investigation £86
95004 Percutaneous tests (scratch, puncture, skin prick) with allergenic extracts, immediate type reaction, specify number of tests; includes interpretation and report SPECIALIST MEDICINE Investigation £57
95070 Inhalation bronchial challenge testing (not including necessary pulmonary function tests); with histamine, methacholine, or similar compounds; The reaction is documented SPECIALIST MEDICINE Investigation £198
95071 Inhalation bronchial challenge testing (not including necessary pulmonary function tests); with antigens or gases, specify SPECIALIST MEDICINE Investigation £58
95806 Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement): Reporting code R5806 SPECIALIST MEDICINE Investigation £653
95808 Polysomnography (PSG); sleep staging with 1-3 additional parameters of sleep, attended by a technologist; Reporting code R5808. SPECIALIST MEDICINE Investigation £1,050
95819 Electroencephalogram (EEG) including recording awake and asleep (including hyperventilation and/or photic stimulation when appropriate): Reporting code R5819 SPECIALIST MEDICINE Investigation £653
95827 Electroencephalogram (EEG); all night sleep only: Reporting code R5827 SPECIALIST MEDICINE Investigation £653
96002 Dynamic surface electromyography, during walking or other functional activities, 1-12 muscles SPECIALIST MEDICINE Investigation £89
NIHR_INV_028 Flow Volume Loop SPECIALIST MEDICINE Investigation £70
NIHR_INV_029 Body Box Lung Volume SPECIALIST MEDICINE Investigation £99
NIHR_INV_030 Gas Transfer/ DLCO/ Transfer Factor SPECIALIST MEDICINE Investigation £70
NIHR_INV_031 Cough Challenge SPECIALIST MEDICINE Investigation £198
S0823 6 Minute Walk Test (6MWT) (6-MWT) SPECIALIST MEDICINE Investigation £89
S0857 Short Physical Performance Battery, SPPB, assessment of lower extremity function, performance and mobility disability; includes standing and gait SPECIALIST MEDICINE Investigation £89
T5057 Diagnostic photography, global photography (Formerly QuintilesIMS code 95057) SPECIALIST MEDICINE Investigation £276

Sheet 3: Dept

Workbook content:




This tariff has been created to assist both Industry and NHS partners to create consistent and meaningful costings for Industry sponsored research within the NHS.










Values within this tariff do not include the relevant labour time required by research staff to initiate, carry out or report on the activity described.










All values include an indirect cost and capacity building and therefore only need the addition of the local PbR MFF from the Industry Costing Tool to produce valid figures.










Please note that all values included below are guidelines and may require adaptaion due to complexity, additional staff involvement or eternal third party contracts.










All entries contain the following:
















●       Grantplan or NIHR Coding - Codes from the Industry Grantplan software or NIHR coding (for reference) where Grantplan coding is absent.










●       Activity Description - Brief Description of activity taking place










●       Specialty - Defined service support specialty that covers the activity (this may vary from one NHS organisation to another.










●       Notes - Whether the activity is a single investigation, an intervention with associated investigation or a unit cost activity at setup or during the project.










●       2022/23 Costs - The defined unitary cost for the activity including an indirect element










●       Definition - Any desciptor to identify the reasons behind a value or group of batched values
















Please note that these are NHS costs only and do not represent costs provided by commercial or academic units. A degree of consideration will be required in order to cost any of these items in conjunction with external NHS SLAs contract to either of these entities.










The following tasks are deemed as part of the business service and are considered included in costs already in the costing template and therefore are NOT independently chargeable:




- Set-up of any finance and IT information systems as required




- Invoice generation for all departments




- Any standard tasks performed by the Trust as part of normal or routine patient care




- Any trial related communications




- Any standard administrative or management support and general maintenance of trial related paperwork (NOTE: this EXCLUDES data management)




- Pre-site selection or feasibility tasks




- Arrange/attend any introduction or qualification meetings




- Time research time spend preparing or attending inspections by regulatory bodies




- Time for any regulatory body inspections




- Medical record retrieval




- Internal contracts or paperwork for staff i.e. honorary contracts or University – Trust agreements for research staff




- PI duty of care responsibilities including Investigator review of safety reporting provided by COMPANY e.g. annual safety reports




- Storage space/co-ordination of equipment/notes




- Pre-screening (e.g. note searches) for non-stratified medicine/rare disease studies, however cost coverage for stratified medicine rare disease/study pre-screening resulting in significant workload for the participating organisation (e.g. data not recorded in routine patient notes) to be agreed on a study-by-study basis as required.




- Company audits (if necessary Company and Trust can negotiate a cost for a company requested audit with above-standard time requirements for staff involved)















Grantplan or NIHR Coding Activity Description Department Notes 2022/23 Definition
NIHR_DEPT_001 General R&D fee General Departments Setup £1,096 Costing and model agreement negotiation across organisation for final agreement, including any sub-contracts/service level agreement/honorary contracts as required.

Coordination of practical arrangements for confirmation of local capability and capacity across the organisation as required by HRA Approval. Further information is available in the CRN principles of good practice (link to be included to document). NOTE: Assessment is considered part of site selection and covered by the indirect and capacity building elements of the template.

Research management activities, such as investigator file set-up and maintenance, including performance oversight for set-up and recruitment activities to deliver contracted requirements.

Co-ordination of all close-down activities across the organisation to met Sponsor requirements.

Provision of general support for Sponsor to understand organisation requirements in context of UK research environment. Local CRN team is available to provide support as required (link to contacts on website)

Variations to value (increase or decrease) may occur in relation to study or therapy area complexity. The base calculated figure is based upon 30 hours setup time required by Managerial and administrative grade staff
NIHR_DEPT_002 Archiving fee (per box) to be paid upon completion of study General Departments Closedown £549 Per box fee provided for paper archiving by research site for a minimum duration of at least 15 years unless stated otherwise stated. The study specific archive duration is defined by the Sponsor for that study type and where the Clinical Trials Regulation (CTR) EU No 536/2014 is applicable may be at least 25 years. Total charge is expected to be appropriately described in the model agreement financial appendix payment schedule to reflect volume/ required duration relevant for the study.

Fee covers archiving preparation (including site archivist review where necessary), transfer, retrieval, access, indefinite storage and destruction (when instructed by Sponsor at end of agreed archive period) of site related trial material.

Where site utilises an external third party archive, clarification of activities included in any quote should be provided to the Sponsor and the site’s archiving preparation activities in such circumstances should be covered through the indirect/capacity building elements.

Where the Sponsor takes responsibility for study archiving the fee should not be charged and the site’s archiving preparation activities in such circumstances should be covered through the indirect/capacity building elements.

THE COST STATED HERE IS AN ECEONOMY OF SCALE BASED UPON AN AVERAGE OF 3 ARCHVING BOXES BEING REQUIRED. USERS SHOULD NOTE THAT A REQUIREMENT FOR LESS THAN 3 BOXES MAY RESULT IN A HIGHER COST PER BOX.
NIHR_DEPT_003 Chief Investigator fee General Departments Setup £1,594 The Chief Investigator has additional tasks covered by this fee which are associated with:
Ethics and MHRA review of documents
Ethics submission
Ethics meeting attendance
Liaison with ethics assessment team
Attendance at safety meetings throughout study
Submission of Annual Progress Reports/ Development Safety Update Reports
Provision of general medical oversight throughout the study including key teleconferences, Trial management, steering committee meetings to lead on study issues.
Administration support time for activities listed above.

If Chief Investigator involvement is only signature of Ethics form, this fee is not chargeable

Further activities, especially prior to site selection, should be considered as a separate consultancy service which is not covered in this fee. A separate consultancy contract/costing is recommended.
NIHR_DEPT_004 Clinical Research Facility set-up fee (only chargeable when specialist CRF is required for trial conduct or Sponsor has chosen to use facilities for potential study benefits) General Departments Setup £1,535 CRF is not part of standard patient care pathway and thus this resource space in Trusts must be paid for if required
The fee is payable if:
-The Specialist CRF required for trial conduct
-The company/Sponsor has chosen to use CRF due to potential recruitment benefit
No fee should be incurred by Company/Sponsor if Trust encounter capacity restraints and the use of the CRF is only option to retain the study or if there is minimal involvement e.g. room only use (this cost is covered by the indirect costs and should be distributed by the Trust to the CRF)
The fees covers preliminary meetings with the CRF, study review, development, planning, set-up, delivery management and close down.
NIHR_DEPT_005 Category A or B amendment fee (chargeable per amendment) General Departments In Flight £313 Only chargeable for category A or B amendments at that site requiring a change in documentation or process to conduct the study. Includes Review/implementation time by all relevant staff/departments for implementation, review and distribution.
NIHR_DEPT_006 Training Fee (per hour per attending staff member) to be paid upon completion of training visits General Departments Setup £81
NIHR_DEPT_007 Monitoring Fee (per hour per attending staff member) to be paid quarterly in arrears General Departments In Flight £81
NIHR_DEPT_008 Set-up fee per Patient Inclusion Centre (PIC) used by site General Departments Setup £274 Patient Identification Centre (PIC) payments, including hub and spoke models, for GP surgeries must be based on work performed with consideration for timeframes and can be capped using relevant wording in the financial arrangements in the contract.
Tasks involved are, but not limited to:
• Database searches
• Letter generation (packaging and postage excluded from fee and should be reimbursed as relevant to volume)
• Patient follow-up including follow-up of non-responders (if covered in ethics application)
• Tracking
The guide fee assumes standard charge for note searches but could increase for complex searches or requires large numbers of letter generated.

The base calculated figure is based upon 3 hours setup time required by Medical and administrative grade staff.

The separate screening fee per randomised patient covers any source data verification work or support work the referral may require in relation to participation in the research. This should only be charged where additional work to that covered under the set-up tasks is required for the patient to participate
NIHR_DEPT_009 Successful screening fee per randomised patient at PIC to be paid quarterly in arrears General Departments In Flight £55 The base calculated figure is based upon 0.5 hours time required by Medical and administrative grade staff.
NIHR_DEPT_010 Refreshments for Patients (applicable for visits lasting over 3 hours) to be paid quarterly in arrears - Study Subject Related Expenses and Allowances General Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_011 Refreshments for Carers (applicable for visits lasting over 3 hours) to be paid quarterly in arrears - Study Subject Related Expenses and Allowances General Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_012 Inconvenience payment for patients as agreed by ethics to be paid quarterly in arrears - Study Subject Related Expenses and Allowances General Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_013 Maximum patient travel costs per visit* to be paid quarterly in arrears - Study Subject Related Expenses and Allowances General Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_014 Expenses for chief investigator attendance at Ethics meeting General Departments Setup TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_015 Audiology Departments Setup Audiology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_016 Cardiovascular Departments Setup Cardiovascular Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_017 Dental Departments Setup Dental Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_018 Genetics Departments Setup Genetics Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_019 Immunology or Virology Departments Setup Immunology or Virology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_020 Interventional Diagnostics Departments Setup Interventional Diagnostics Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_021 Microbiology Departments Setup Microbiology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_022 Nuclear Medicine Departments Setup Nuclear Medicine Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_023 Ophthalmology Departments Setup Ophthalmology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_024 Radiology Additional scanning reports (e.g. RECIST, iRECIST etc) to be paid quarterly in arrears Radiology Departments In Flight £140
NIHR_DEPT_025 Radiology CRE Assessment Radiology Departments Setup £274
NIHR_DEPT_026 Radiology MPE Assessment Radiology Departments Setup £274
NIHR_DEPT_027 Radiology Phantom MRI Scans (inc Radiographer Training Time) Radiology Departments Setup £580
NIHR_DEPT_028 Radiology Phantom CT Scans (inc Radiographer Training Time) Radiology Departments Setup £350
NIHR_DEPT_029 Radiology Imaging Transfer to CD or Sponsor provided Soft or Hardware to be paid quarterly in arrears Radiology Departments In Flight £32
NIHR_DEPT_030 Radiology extending working hours (per hour) to be paid quarterly in arrears Radiology Departments In Flight £81 Extended hours are defined as work added onto the normal working hours (09:00-17:00 Monday to Friday), but not necessarily starting in working hours, for example CT dispensing required on a Tuesday 17:00-18:30. Whereas out-of-hours work is defined as weekend work or late evenings not following on from normal working hours, for example CT dispensing on a Tuesday 20:00-21:30 or Saturday morning
NIHR_DEPT_031 Radiology CRA-requested dedicated Imaging staff time to support monitoring visits. Provision of basic access, hospitality, documentation provision and query response (per hour) to be paid quarterly in arrears Radiology Departments In Flight £81
NIHR_DEPT_032 Rqadiology revision of relevant SOPs or Imaging documentation as a result of a substantial protocol amendment (per hour) to be paid quarterly in arrears Radiology Departments In Flight £81
NIHR_DEPT_033 Radiotherapy Setup Radiotherapy Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_034 Specialist Medicine Setup Specialist Medicine Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_035 Pharmacy A: Dispensary based dispensing only with no aseptic dispensing Pharmacy Departments Setup £1,772 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 21.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_036 Pharmacy B: Aseptic dispensing only Pharmacy Departments Setup £2,044 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 21.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_037 Pharmacy C: Dispensary and aseptic dispensing Pharmacy Departments Setup £2,453 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 30 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_038 Pharmacy D: Cell based Gene Therapy setup Pharmacy Departments Setup £31,640 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 385 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_039 Pharmacy Set-up/close down for each additional site within the same NHS Trust (charged per site) Pharmacy Departments Setup £209 The base calculated figure is based upon 2.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_040 Pharmacy IMP Management Fee per year per site (Annualised charge - pro rata as needed) to be paid quarterly in arrears Pharmacy Departments In Flight £601 The IMP Management Fee is applicable to all studies requiring IMP management by an NHS Pharmacy.
Full costs are chargeable unless Sponsor/CRO provide evidence and/ or information for specific Pharmacy requirements resulting in a suitable negotiated fee.
Charged as an annual fee, which can be calculated pro rata as required, for the duration of the trial unless otherwise agreed and documented in the trial agreement.
Stock checks are deemed part of routine standard practice, however any additional requirements (e.g. reporting or Company requested stock checks) may be charged as additional fees.
Charged from month of site initiation visit to month of site close out visit. The following activities are included in as IMP Management Activities:

Temperature management activities other than providing evidence of temperature to sponsors

Temperature excursion management

Expiry date checking
NIHR_DEPT_041 Pharmacy Prescription Charge to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site. Standard NHS Prescription charge to be added directly to contract if applicable
NIHR_DEPT_042 Pharmacy Storage space per month to cover charge incurred by Pharmacy for additional space within each NHS Trust regardless of temperature requirements (per site charge as required) Pharmacy Departments In Flight £55
NIHR_DEPT_043 Pharmacy Receiving Shipment to be paid quarterly in arrears Pharmacy Departments In Flight £55
NIHR_DEPT_044 Pharmacy Waste disposal management inc paperwork, logs etc to be paid quarterly in arrears Pharmacy Departments In Flight £45
NIHR_DEPT_045 Pharmacy Packaging returns for return to sponsor to be paid quarterly in arrears Pharmacy Departments In Flight £33
NIHR_DEPT_046 Pharmacy Specialist storage requirements for advanced therapy/radiopharmaceuticals (e.g. dry shipper containing liquid nitrogen or minus 80C freezers) (per site charge as required) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_047 Pharmacy Specialist transportation requirements for advanced therapy/radiopharmaceuticals (e.g. dry shipper, dry ice, spillage kits, courier costs) (per site charge as required) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_048 Pharmacy Waste disposal storage pending collection or disposal of all medicines originally supplied by Sponsor per month or part thereof (per site charge as required). Chargeable only if not collected within 1 month of the first request to collect Pharmacy Departments In Flight £27 Patient returns storage, usually not monitored.
NIHR_DEPT_049 Pharmacy Storage or disposal of all unused/expired medicines originally supplied by Sponsor. Chargeable if not collected within 1 month of the first request and to be paid per month quarterly in arrears. Pharmacy Departments In Flight £55 Unused/expired stock at the end of the study that never left pharmacy and has to be maintained in quarantine (temperature monitored) until the Sponsor collects/reconciles.
NIHR_DEPT_050 Pharmacy Re-labelling and releasing of IMP batch (Usual staff hourly rate) to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_051 Pharmacy Extending working hours (Usual staff hourly rate + 50%) to be paid quarterly in arrears Pharmacy Departments In Flight £121 Extended hours are defined as work added onto the normal working hours (09:00-17:00 Monday to Friday), but not necessarily starting in working hours, for example CT dispensing required on a Tuesday 17:00-18:30. Whereas out-of-hours work is defined as weekend work or late evenings not following on from normal working hours, for example CT dispensing on a Tuesday 20:00-21:30 or Saturday morning
NIHR_DEPT_052 Pharmacy Out-of-hours working (Usual staff hourly rate + 100%) to be paid quarterly in arrears Pharmacy Departments In Flight £161 Extended hours are defined as work added onto the normal working hours (09:00-17:00 Monday to Friday), but not necessarily starting in working hours, for example CT dispensing required on a Tuesday 17:00-18:30. Whereas out-of-hours work is defined as weekend work or late evenings not following on from normal working hours, for example CT dispensing on a Tuesday 20:00-21:30 or Saturday morning
NIHR_DEPT_053 Pharmacy Pharmacy staff time to support monitoring visits inc remote monitoring. Chargeable on an hourly rate to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_054 Pharmacy IVRS/ study specific training as required by sponsor. Chargeable on an hourly rate. to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_055 Pharmacy Individual training sessions for handling and preparation of study advanced therapy/radiopharmaceutical (usual staff hourly rate) to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_056 Pharmacy Time to assess whether revision of relevant SOPs or IMP documentation is required as a result of a protocol, Investigational Brochure or pharmacy manual amendment (Usual staff hourly rate) to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_057 Pharmacy Sponsor requested stock or temperature checks (Usual staff hourly rate) to be paid quarterly in arrears Pharmacy Departments In Flight £81
NIHR_DEPT_058 Pharmacy IMP release by Qualified Person (QP), if required (QP actual hourly rate) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_059 Pharmacy Study or IMP specific consumables for Pharmacy (total cost) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_060 Pharmacy Equipment purchase for specific IMP requirements in storage space or conditions (total cost) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_061 Device/ Clinical Equipment Courier/ posting costs for IMPs (third party costs as required e.g. per patient, sponsor returns) to be paid quarterly in arrears Pharmacy Departments In Flight TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_062 Device/ Clinical Equipment A: Supply or device is to be checked and reviewed by only the research team Device/ Clinical Equipment Setup £76
NIHR_DEPT_063 Device/ Clinical Equipment B: Consultation with only one Trust service support department or other provider (e.g., Medical Physics, Electrical Engineering, Lab Based Medicines or Other specialists departments or providers) Device/ Clinical Equipment Setup £149
NIHR_DEPT_064 Device/ Clinical Equipment C: Consultation with more than one department Device/ Clinical Equipment Setup £223
NIHR_DEPT_065 Device/ Clinical Equipment D: No consultation with research staff required Device/ Clinical Equipment Setup TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_066 Device/ Clinical Equipment Device Management Fee per month per site to be paid quarterly in arrears Device/ Clinical Equipment In Flight £81 The Trial Maintenance Activities fee covers:
Routine stock checks
Stock and accessory ordering and invoicing
Device maintenance
Contenting for device failure, malfunction, removal and returns
Equipment sterilisation
Regular checking and testing of equipment
Maintaining the accountability log
Tracking of device
Communications with the company
NIHR_DEPT_067 Pathology Setup Pathology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_068 Radiology Setup Radiology Departments Setup £274 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set up supply systems
Train all relevant departmental staff, as required
Close down. The base calculated figure is based upon 7.5 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_069 Pharmacy Specialist profession oversight fee for advanced therapies or radiopharmaceuticals. Annulised charge pro rata as needed Pharmacy Departments Setup TBC To be discussed directly between Sponsor and local site
NIHR_DEPT_072 Pharmacy E: Virus based Gene Therapy setup Pharmacy Departments Setup £8,437 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 102 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_073 Pharmacy F: Somatic Cell Therapy setup Pharmacy Departments Setup £21,093 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 256 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_074 Pharmacy G: Tissue engineered product setup Pharmacy Departments Setup £21,093 Review protocol
Feasibility assessment
Communication with the sponsor
Participation in mandatory local review and approval processes
Attendance at meetings & liaison with PI, Research Nurse, CRA
Write bespoke SOPs, associated documents and worksheets
Set up dispensing & stock control software systems and documentation
Set-up electronic prescribing and Pharmacy systems, where applicable
Set up supply systems
Train all relevant Pharmacy staff, as required
Review contract including pharmacy costing
Close down. The base calculated figure is based upon 256 hours setup time required by Managerial and administrative grade staff.
NIHR_DEPT_075 Full Day non-triggered Sponsor/ CRO audit Study Team In Flight £1,028 Communication with the sponsor
Participation in mandatory processes as dictated by audit requirements
Attendance at meetings & liaison with PI, Research Nurse, CRA
Presentation of bespoke SOPs, associated documents and worksheets
Presentation of dispensing & stock control software systems and documentation
Presentation of training logs for all relevant departmental staff, as required
All other activity as required by statutory audit requirements The base calculated figure is based upon 8 hours setup time required by Medical and grade staff.
NIHR_DEPT_076 Medical Staff Out-of-hours working (Usual staff hourly rate + 100%) to be paid quarterly in arrears Study Team In Flight £194 Extended hours are defined as work added onto the normal working hours (09:00-17:00 Monday to Friday), but not necessarily starting in working hours, for example CT dispensing required on a Tuesday 17:00-18:30. Whereas out-of-hours work is defined as weekend work or late evenings not following on from normal working hours, for example signatures or prescriptions on a Tuesday 20:00-21:30 or Saturday morning

The words contained in this file might help you see if this file matches what you are looking for:

...Sheet procedures version workbook content this definition and tariff has been created to assist both industry nhs partners create consistent meaningful costings for sponsored research within the values solely define relevant labour time required by staff initiate carry out or report on activity described investigation intervention document please note that all included below are guidelines may require adaptaion due complexity additional involvement entries contain following nbsp grantplan nihr coding codes from software reference where is absent description brief of taking place department defined covers vary one organisation another notes whether a single an with associated unit cost at setup during project timings unitary these baseline timimgs only do not represent costs provided commercial academic units degree consideration will be in order any items conjunction external slas contract either entities have used convert into tool role per hour medical pound manager nurse admin data ...

no reviews yet
Please Login to review.